Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

_See the full regCOVID repository with detailed results at https://github.com/lhncbc/r-snippets-bmi/tree/master/regCOVID

Study Counts

Type Study_count
Total_Studies 1217
interventional 623
Observational 501
Registry 93

Studies over Time

Total studies by type over time

Total studies by type over time

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 110
Drug|placebo 86
Drug|Drug 59
Biological 45
Other 41
Behavioral 22
Device 22
Drug|Other 19
Diagnostic Test 17
Drug|Drug|Drug 15
Drug|Drug|placebo 15
Procedure 14
Biological|placebo 13
Biological|Biological 11
Other|Other 10
Device|Device 8
Drug|Drug|Drug|Drug 8
Biological|Other 6
Behavioral|Behavioral 5
Biological|Drug 5
Device|Other 5
Dietary Supplement 5
Drug|Drug|Other 5
Drug|Drug|Drug|placebo 4
Drug|Drug|placebo|placebo 4
Procedure|Procedure 4
Drug|Drug|Drug|Other 3
Radiation 3
Behavioral|Behavioral|Behavioral 2
Biological|Drug|placebo 2
Device|placebo 2
Device|Procedure 2
Diagnostic Test|Diagnostic Test 2
Dietary Supplement|Dietary Supplement 2
Dietary Supplement|Drug|placebo 2
Dietary Supplement|Other 2
Drug|Drug|Drug|Drug|Drug 2
Behavioral|Diagnostic Test|Diagnostic Test 1
Biological|Biological|Biological|Biological 1
Biological|Biological|Biological|Biological|Biological|Biological|placebo|placebo 1
Biological|Biological|Biological|Biological|placebo 1
Biological|Biological|Biological|Biological|placebo|placebo 1
Biological|Biological|Biological|Drug 1
Biological|Biological|Biological|Genetic|Other 1
Biological|Biological|Other 1
Biological|Biological|placebo 1
Biological|Device|Device|Other|Other 1
Biological|Drug|Drug|Drug|Drug|Drug 1
Biological|Drug|Drug|Drug|placebo|placebo 1
Biological|Other|placebo 1
Combination Product 1
Combination Product|Combination Product|Drug|Drug 1
Combination Product|Drug 1
Device|Device|Device 1
Device|Drug 1
Device|Drug|Drug|Drug|Drug|Drug|Drug|Drug|Radiation 1
Device|Drug|Drug|Drug|Drug|Drug|Drug|Radiation 1
Device|Drug|Drug|Procedure 1
Device|Drug|Drug|Procedure|Procedure 1
Diagnostic Test|Diagnostic Test|Diagnostic Test|Diagnostic Test|Diagnostic Test 1
Diagnostic Test|Diagnostic Test|Diagnostic Test|Drug|Drug|Other|placebo 1
Diagnostic Test|Other 1
Dietary Supplement|Dietary Supplement|Dietary Supplement|Other 1
Dietary Supplement|Drug 1
Dietary Supplement|Drug|Drug|Other 1
Dietary Supplement|placebo 1
Drug|Drug|Drug|Drug|Drug|Drug 1
Drug|Drug|Drug|Drug|Drug|Drug|Drug|Drug|Drug|Drug|Drug 1
Drug|Drug|Drug|Drug|Drug|Drug|Drug|Other|placebo 1
Drug|Drug|Drug|Drug|Other 1
Drug|Other|placebo 1
Drug|placebo|Procedure|Procedure|Procedure|Procedure 1
Drug|placebo|Radiation 1
Drug|Procedure 1
Other|Other|Other 1
Other|Procedure 1
Procedure|Procedure|Procedure 1
Procedure|Procedure|Procedure|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Intervention_type intervention Study_count Date of First Study
placebo placebo 143 2020-02-20
Drug hydroxychloroquine 97 2020-02-06
Other standard care 59 2020-01-23
Biological convalescent plasma 52 2020-03-23
Drug azithromycin 29 2020-03-23
Drug tocilizumab 24 2020-03-09
Drug ritonavir 23 2020-01-28
Drug lopinavir 20 2020-01-28
Drug lopinavir/ritonavir 19 2020-01-30
Biological mesenchymal stem cells 17 2020-01-27
Drug chloroquine 14 2020-03-19
Drug saline 13 2020-03-25
Device oxygen 12 2020-03-19
Biological blood sample 11 2020-03-09
Drug colchicine 11 2020-03-23
Drug interferon 10 2020-02-11
Drug methylprednisolone 10 2020-01-23
Other prone positioning 10 2020-03-26
Biological plasma 9 2020-04-09
Biological control 8 2020-03-24
Drug favipiravir 8 2020-03-09
Drug hydroxychloroquine / azithromycin 8 2020-03-23
Drug remdesivir 8 2020-02-20
Drug baricitinib 7 2020-03-24
Drug ivermectin 7 2020-04-05
Drug sarilumab 7 2020-03-15
Drug enoxaparin 6 2020-04-07
Drug losartan 6 2020-03-13
Drug vitamin c 6 2020-02-04
Drug anakinra 5 2020-03-25
Biological bcg 5 2020-03-25
Drug dexamethasone 5 2020-03-25
Drug heparin 5 2020-04-24
Drug nitazoxanide 5 2020-04-03
Drug nitric oxide 5 2020-03-09
Radiation radiotherapy 5 2020-05-04
Drug ruxolitinib 5 2020-04-01
Other telehealth 5 2020-03-21
Drug arbidol 4 2020-01-30
Procedure biological samples 4 2020-03-23
Drug bromhexine hydrochloride 4 2020-02-14
Drug clazakizumab 4 2020-04-09
Biological nk cells 4 2020-02-13
Diagnostic Test pcr 4 2020-04-02
Other questionnaire 4 2020-03-08
Other ace inhibitor 3 2020-03-30
Diagnostic Test blood test 3 2020-04-24
Drug budesonide 3 2020-04-15
Drug corticosteroid 3 2020-05-04
Drug lenzilumab 3 2020-03-31
Drug oseltamivir 3 2020-02-02
Drug peginterferon 3 2020-03-27
Drug povidone/iodine 3 2020-04-08
Diagnostic Test serology 3 2020-04-08
Combination Product NA 2 2020-02-27
Biological adenovirus type 5 vector 2 2020-03-15
Drug anticoagulation 2 2020-04-20
Drug aspirin 2 2020-04-01
Dietary Supplement ayurveda 2 2020-04-10
Other best available therapy 2 2020-04-07
Drug bevacizumab 2 2020-02-14
Other blood 2 2020-05-01
Behavioral blood donation sms 2 2020-04-28
Other blood draw 2 2020-04-03
Biological bnt162a1 2 2020-04-27
Biological bnt162b1 2 2020-04-27
Biological bnt162b2 2 2020-04-27
Biological bnt162c2 2 2020-04-27
Drug camostat mesilate 2 2020-03-23
Drug canakinumab 2 2020-04-24
Drug chloroquine/hydroxychloroquine 2 2020-03-06
Drug cholecalciferol 2 2020-04-09
Drug clopidogrel 2 2020-04-01
Device cpap 2 2020-04-09
Diagnostic Test ct-scan 2 2020-04-22
Device cytokine adsorption 2 2020-04-21
Dietary Supplement honey 2 2020-03-23
Drug hydroxychloroquine/placebo 2 2020-04-05
Drug ibuprofen 2 2020-04-02
Drug imatinib 2 2020-04-07
Drug immunoglobulin 2 2020-04-08
Biological inactivated sars-cov-2 vaccine 2 2020-04-14
Biological low 2 2020-04-24
Device lung ultrasound 2 2020-04-04
Behavioral meditation 2 2020-05-01
Combination Product mefloquine 2 2020-04-07
Behavioral mindfulness 2 2020-05-04
Biological mrna-1273 2 2020-02-21
Drug n-acetylcysteine 2 2020-05-01
Device nasal rinse 2 2020-04-08
Dietary Supplement nigella sativa 2 2020-05-21
Procedure ophthalmologic exam 2 2020-04-29
Other physical therapy 2 2020-04-24
Dietary Supplement probiotic 2 2020-04-27
Drug pul-042 2 2020-03-16
Drug rivaroxaban 2 2020-04-01
Diagnostic Test saliva 2 2020-04-22
Drug sevoflurane 2 2020-03-26
Drug siltuximab 2 2020-03-31
Drug sirolimus 2 2020-04-05
Drug standard therapy 2 2020-04-08
Dietary Supplement vitamin d 2 2020-04-25
Dietary Supplement vitamin super b-complex 2 2020-04-08
Dietary Supplement zinc 2 2020-04-08
Combination Product - tocilizumab 1 2020-04-07
Drug -interferon nebulization 1 2020-02-27
Other “calm” is a mindfulness meditation mobile app 1 2020-03-26
Drug 1200 mg) 1 2020-05-23
Biological 14-day schedule 1 2020-05-21
Drug 1600 mg) 1 2020-05-23
Drug 18f-î±vî²6-bp 1 2020-05-03
Biological 28-day schedule 1 2020-05-21
Biological aapc 1 2020-03-05
Drug abx464 1 2020-05-18
Drug ace inhibitor, angiotensin receptor blocker 1 2020-04-14
Drug acetylsalicylic acid 1 2020-04-23
Device actigraphy 1 2020-04-24
Drug activase 1 2020-04-18
Other adjuvant 1 2020-04-24
Other after-each-case room disinfection 1 2020-05-19
Other albumine 1 2020-05-26
Drug allogeneic 1 2020-04-22
Drug alpha one antitrypsin 1 2020-05-10
Procedure alveolar 1 2020-04-22
Drug amiodarone 1 2020-04-14
Drug anakinra/osoc 1 2020-04-17
Biological angiotensin peptide (1-7) derived plasma 1 2020-05-01
Drug anluohuaxian 1 2020-04-01
Biological anti-coronavirus antibodies (immunoglobulins)obtained with dfpp from convalescent patients 1 2020-04-09
Diagnostic Test antibody test 1 2020-05-08
Drug antihypertensives 1 2020-04-10
Behavioral anxiety reduction training 1 2020-05-11
Other arb 1 2020-04-14
Drug arbidol hydrochloride/interferon atomization 1 2020-02-02
Drug artemic 1 2020-05-07
Dietary Supplement asbrip 1 2020-05-25
Drug asc09 1 2020-02-04
Drug asc09f/oseltamivir 1 2020-02-04
Dietary Supplement ascorbic acid/zinc gluconate 1 2020-04-08
Drug at-001 1 2020-04-25
Drug atorvastatin 1 2020-04-01
Drug atovaquone 1 2020-04-07
Drug atovaquone/azithromycin 1 2020-04-07
Behavioral attention bias modification (abm) 1 2020-04-24
Drug atyr1923 1 2020-06-01
Procedure auditory evoked potentials (aep) 1 2020-05-08
Procedure auricular neuromodulation 1 2020-04-07
Biological avdoralimab 1 2020-04-29
Drug aviptadil 1 2020-03-14
Drug aviptadil/standard care 1 2020-03-14
Drug azoximer bromide 1 2020-05-07
Biological bacille calmette-guã©rin (bcg) 1 2020-05-04
Drug best supportive care 1 2020-04-01
Drug best supportive care (bsc) / ifx-1 1 2020-04-01
Drug bhv-3500 1 2020-04-09
Device bidirectional oxygenation mouthpiece 1 2020-03-25
Biological biological 1 2020-05-01
Device biosensor 1 2020-04-01
Device biovitals 1 2020-02-20
Drug bld-2660 1 2020-04-02
Procedure blink 1 2020-05-08
Procedure blink/masseter inhibitory reflex 1 2020-05-08
Other blood/derivatives 1 2020-04-02
Drug bms-986253 1 2020-04-02
Drug bromhexine oral tablet and/or hydroxychloroquine tablet 1 2020-04-15
Drug calcium channel blockers 1 2020-03-30
Drug candesartan 1 2020-04-10
Device caption ai 1 2020-04-03
Other cash transfer 1 2020-04-16
Biological castem 1 2020-02-06
Drug cd24fc 1 2020-03-19
Biological cell therapy protocol 1 1 2020-04-20
Biological cell therapy protocol 2 1 2020-04-20
Device cellectraâ® 2000 1 2020-04-03
Device centricyte 1000 1 2020-03-26
Biological chadox1 1 2020-03-20
Behavioral chat-based instant messaging support 1 2020-05-26
Other chemokines profiles of patients with dexmedetomidine administration 1 2020-04-21
Diagnostic Test chest ct 1 2020-04-30
Drug chlorhexidine 1 2020-04-08
Drug clarithromycin 1 2020-05-17
Drug clevudine 1 2020-04-14
Procedure clinical examination 1 2020-04-14
Drug cm4620 1 2020-04-07
Drug cobicistat 1 2020-01-29
Drug colchicine/herbal phenolic monoterpene fractions 1 2020-05-15
Other collection of samples 1 2020-04-22
Diagnostic Test complement dosage 1 2020-04-13
Diagnostic Test conjunctival swab 1 2020-04-22
Other continuation of acei 1 2020-04-14
Other continuation of acei/arb 1 2020-04-14
Other continuation of arb 1 2020-04-01
Drug continuation of ras blocker 1 2020-03-28
Device continuous positive airway pressure 1 2020-05-12
Device control swab 1 2020-04-24
Drug conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation, 1 2020-01-28
Drug conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir) 1 2020-01-28
Drug conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)/traditional chinese medicines (tcms) granules 1 2020-01-28
Behavioral coping strategies video 1 2020-04-29
Device coviage 1 2020-05-14
Other covid-19 patients 1 2020-05-10
Procedure csvf 1 2020-03-26
Diagnostic Test ctus examination 1 2020-04-30
Drug cumin 1 2020-04-11
Other cupping 1 2020-04-20
Other current care per ucla treating physicians 1 2020-04-14
Drug cyclosporine 1 2020-05-03
Diagnostic Test cytokines 1 2020-04-13
Device cytosorb 1 2020-04-09
Behavioral daily coping toolkit 1 2020-05-20
Other daily room disinfection 1 2020-05-19
Procedure dalargin 1 2020-04-08
Drug danoprevir 1 2020-04-10
Drug danoprevir/ritonavir 1 2020-04-10
Drug dapagliflozin 1 2020-04-14
Drug darunavir 1 2020-01-29
Drug darunavir/cobicistat 1 2020-01-29
Drug das181 1 2020-03-25
Diagnostic Test data collection 1 2020-03-20
Diagnostic Test data collection/rhinopharyngeal swab 1 2020-03-20
Drug day 1 2020-05-07
Drug deferoxamine 1 2020-04-01
Drug defibrotide 1 2020-04-08
Drug defibrotide 25 mg/kg 24 hours continuous infusion for 15 days 1 2020-04-08
Other derivatives. 1 2020-04-02
Combination Product device) 1 2020-04-09
Drug dexamethasone/hydroxychloroquine 1 2020-04-09
Drug dfv890 1 2020-05-08
Behavioral digital health online platform 1 2020-05-21
Drug diovan 1 2020-04-02
Drug dipyridamole 1 2020-05-15
Other discontinuation of acei 1 2020-04-14
Other discontinuation of acei/arb 1 2020-04-14
Other discontinuation of arb 1 2020-04-01
Drug discontinuation of ras blocker 1 2020-03-28
Other distance learning 1 2020-04-27
Drug dociparastat sodium 1 2020-05-13
Drug dornase alfa 1 2020-05-20
Drug doxycycline 1 2020-04-26
Device ecco2r 1 2020-04-09
Drug eculizumab 1 2020-04-06
Behavioral educational video 1 2020-04-30
Diagnostic Test eeg 1 2020-05-26
Biological emapalumab 1 2020-03-25
Drug emtricitabine 1 2020-04-02
Drug emtricitabine/tenofovir disoproxil 1 2020-04-02
Device endoscopy 1 2020-05-09
Drug enoxaparin/lovenox 1 2020-04-27
Diagnostic Test ep 1 2020-05-26
Drug escin 1 2020-03-23
Drug estradiol 1 2020-04-21
Drug etoposide 1 2020-04-17
Other exercise group 1 2020-05-07
Other experimental: questionnaire without precaution information 1 2020-03-08
Drug famotidine 1 2020-04-27
Drug favipiravir / standard care 1 2020-04-16
Drug favipiravir/azithromycin 1 2020-05-23
Drug favipiravir/chloroquine 1 2020-03-20
Drug favipiravir/hydroxychloroquine 1 2020-05-23
Drug favipiravir/tocilizumab 1 2020-03-09
Biological fecal swab 1 2020-04-28
Diagnostic Test filmarray pneumonia 1 2020-05-06
Drug fingolimod 1 2020-02-20
Drug fluoxetine 1 2020-04-18
Drug fluvoxamine 1 2020-04-08
Drug folic acid 1 2020-04-16
Drug fondaparinux 1 2020-04-23
Drug formoterol 1 2020-03-30
Drug fuzheng huayu 1 2020-02-15
Device gammacoreâ® (vagus nerve stimulation) 1 2020-04-20
Device gammacoreâ® sapphire (non-invasive vagus nerve stimulator) 1 2020-04-14
Drug ganovo 1 2020-02-27
Drug ganovo/ritonavir//-interferon nebulization 1 2020-02-27
Drug gargle 1 2020-04-25
Other gas exchanges at different peep 1 2020-04-13
Drug gimsilumab 1 2020-04-15
Drug gls-1200 1 2020-05-22
Device go2 peep mouthpiece 1 2020-03-31
Behavioral guided online support program 1 2020-03-26
Behavioral hads 1 2020-04-28
Other hemodynamics changes at different peep 1 2020-04-13
Drug herbal phenolic monoterpene 1 2020-05-15
Device high flow nasal cannula (hfnc) 1 2020-03-26
Other home-cov rule implementation 1 2020-04-05
Other home care monitoring 1 2020-04-14
Device home pulse oximetry monitoring 1 2020-04-30
Behavioral hope intervention 1 2020-03-31
Drug hormones 1 2020-03-25
Biological human amniotic fluid 1 2020-03-22
Drug hydrocortisone 1 2020-04-11
Device hydrogen oxygen generator with nebulizer 1 2020-04-29
Combination Product hydroxychloroquine/azithromycin/ tocilizumab 1 2020-04-07
Drug hydroxychloroquine/chloroquine 1 2020-03-25
Drug hydroxychloroquine/clindamycin 1 2020-04-11
Drug hydroxychloroquine/clindamycin/primaquine 1 2020-04-11
Drug hydroxychloroquine/doxycycline 1 2020-04-11
Drug hydroxychloroquine/famotidine 1 2020-04-27
Drug hydroxychloroquine/ivermectin 1 2020-05-01
Drug hydroxyvitamin 1 2020-05-11
Combination Product hyperbaric oxygen 1 2020-04-09
Drug ibrutinib 1 2020-05-04
Drug icosapent ethyl 1 2020-05-29
Other icu recovery 1 2020-05-12
Other icu recovery / physical therapy 1 2020-05-12
Drug ifx-1 1 2020-04-01
Device igg 1 2020-04-24
Diagnostic Test igg antibody test 1 2020-04-13
Device igg/igm rapid test 1 2020-04-24
Drug igiv 1 2020-05-18
Device igm antibodytest 1 2020-04-24
Diagnostic Test igm/igg rapid test 1 2020-04-13
Drug indomethacin 1 2020-04-08
Other inflammatory cytokines 1 2020-04-21
Other inflammatory cytokines/chemokines profiles of patients with dexmedetomidine administration 1 2020-04-21
Biological injection 1 2020-02-17
Drug ino-4800 1 2020-04-03
Drug interferon-î² 1a 1 2020-04-14
Drug interleukin 1 2020-05-05
Behavioral intermittent 1 2020-04-24
Behavioral internet-based self-help 1 2020-05-07
Behavioral internet-based self-help after 3 weeks 1 2020-05-07
Behavioral internet-delivered cognitive behavior therapy (icbt) for dysfunctional worry related to the covid-19 pandemic 1 2020-04-07
Other interview by psychologists 1 2020-05-19
Device intraosseous 1 2020-04-23
Device intravenous 1 2020-04-23
Drug intravenous drug 1 2020-03-26
Drug iodine 1 2020-04-08
Drug ivermectin (iver pâ®) arm will receive ivm 600 âµg 1 2020-05-05
Drug ivermectin (iver pâ®) arm will receive ivm 600 âµg / kg once daily/standard care. control arm will receive standard care. 1 2020-05-05
Other kb109 1 2020-06-01
Other kb109 / self supportive care (ssc) 1 2020-06-01
Device kerecis 1 2020-04-20
Device kerecis oral/nasal spray 1 2020-04-20
Drug ketamine 1 2020-04-26
Drug kg 1 2020-06-01
Drug kg 24 hours continuous infusion for 15 days 1 2020-04-08
Drug kg once daily 1 2020-05-05
Behavioral kundalini yoga 1 2020-05-11
Behavioral kundalini yoga/anxiety reduction training 1 2020-05-11
Biological lactated 1 2020-04-22
Procedure laryngoscopy 1 2020-04-24
Drug leaf-4l6715 1 2020-05-05
Drug leaf-4l7520 1 2020-05-05
Drug leflunomide 1 2020-04-22
Drug levamisole 1 2020-03-30
Drug levamisole / budesonide/formoterol 1 2020-03-30
Drug levilimab 1 2020-05-19
Drug liberase enzyme 1 2020-03-26
Drug lopinavir/ritonavir / hydoxychloroquine 1 2020-03-30
Drug lovenox 1 2020-04-27
Biological low/upper respiratory tract sample 1 2020-04-28
Diagnostic Test lung impedance 1 2020-05-23
Other lung mechanics at different peep 1 2020-04-13
Biological lv-smenp-dc vaccine 1 2020-02-17
Biological lv-smenp-dc vaccine/antigen-specific ctls 1 2020-02-17
Drug ly3127804 1 2020-04-10
Drug ly3819253 1 2020-05-29
Device magpro x100 stimulator, b70 fluid-cooled coil 1 2020-05-08
Other maintenance 1 2020-04-07
Device marker therapeutics d2000 cartridge (d2000) for use with the spectra optiaâ® apheresis system (optia spd protocol) 1 2020-04-20
Device mask 1 2020-04-08
Procedure masseter inhibitory reflex 1 2020-05-08
Drug mavrilimumab 1 2020-05-21
Other maximal effort test 1 2020-04-24
Drug mcn (methylene blue, vitamin c, n-acetyl cysteine) 1 2020-04-29
Procedure mechanical ventilation 1 2020-04-09
Behavioral meditation/anxiety reduction training 1 2020-05-11
Biological medium dosage inactivated sars-cov-2 vaccine on a 0- 1 2020-05-21
Biological medium dosage inactivated sars-cov-2 vaccine on a 0-/14-day schedule 1 2020-05-21
Biological medium dosage inactivated sars-cov-2 vaccine on a 0-/28-day schedule 1 2020-05-21
Combination Product mefloquine/azithromycin/ tocilizumab 1 2020-04-07
Drug melatonin 1 2020-05-28
Drug melphalan 1 2020-05-06
Biological menacwy 1 2020-03-20
Behavioral mental well-being 1 2020-04-07
Drug meplazumab 1 2020-02-06
Behavioral messaging 1 2020-04-28
Drug metenkefalin 1 2020-04-30
Drug metenkefalin / tridecactide 1 2020-04-30
Drug methylene blue/ vitamin c/n-acetyl cysteine 1 2020-04-29
Behavioral mindfullness training 1 2020-05-04
Behavioral mindfulness session(s) 1 2020-03-20
Device mls laser 1 2020-05-04
Diagnostic Test monitoring visit 1 2020-04-07
Other moxibustion 1 2020-04-20
Other moxibustion/cupping 1 2020-04-20
Drug mstt1041a 1 2020-05-11
Device multifrequency bioimpedance spectroscopy 1 2020-04-14
Biological multistem 1 2020-04-27
Device musclesound ultrasound 1 2020-04-14
Drug n-acetylcysteine/ fuzheng huayu 1 2020-02-15
Drug n-acetylcysteine/placebo 1 2020-02-15
Drug naltrexone 1 2020-04-26
Device neuromuscular 1 2020-04-24
Other neuromuscular electrical stimulation 1 2020-05-08
Diagnostic Test ng test 1 2020-05-27
Dietary Supplement nicotinamide riboside 1 2020-05-22
Drug nigella sativa / black cumin 1 2020-04-11
Device nioâ® (intraosseous access) 1 2020-04-23
Drug nivolumab 1 2020-04-01
Device non-contact mce system 1 2020-03-21
Drug octagam 1 2020-05-29
Drug olokizumab 1 2020-05-06
Drug omeprazole 1 2020-04-01
Behavioral online support group 1 2020-05-05
Diagnostic Test optical coherence tomography (oct) 1 2020-05-21
Drug osoc 1 2020-04-17
Biological otilimab 1 2020-05-04
Other oxygen-ozone 1 2020-04-22
Device oxyhydrogen 1 2020-03-25
Procedure ozone 1 2020-05-11
Drug paracetamol 1 2020-03-20
Behavioral patient-centred advice on telephone consultation in tb patients: 1 2020-05-30
Device pbmt 1 2020-05-08
Device pbmt/smf 1 2020-05-08
Diagnostic Test pcr/serology 1 2020-05-15
Biological pembrolizumab 1 2020-03-31
Diagnostic Test performance evaluation 1 2020-04-30
Behavioral personal exercise intervention 1 2020-05-29
Other phone call 1 2020-04-28
Other physical exercise 1 2020-05-08
Other physiotherapy 1 2020-05-22
Drug piperacillin 1 2020-05-15
Drug piperacillin/tazobactam 1 2020-05-15
Drug pirfenidone 1 2020-02-10
Biological plasma exchange 1 2020-05-02
Drug plitidepsin 1 2020-05-07
Other postural positioning 1 2020-04-10
Drug povidone 1 2020-04-08
Behavioral prayer 1 2020-04-16
Drug prazosin 1 2020-04-24
Other prediction market 1 2020-05-27
Drug prednisone 1 2020-04-10
Procedure procalcitonin 1 2020-04-02
Drug progesterone 1 2020-04-24
Drug prophylactic 1 2020-05-20
Drug prophylaxis 1 2020-03-05
Drug propofol 1 2020-04-21
Device prototype 1 2020-04-24
Other psg 1 2020-04-28
Other pulmonary physiotherapy techniques 1 2020-04-13
Behavioral pulmonary rehabilitation 1 2020-04-23
Drug pulmozyme 1 2020-04-15
Diagnostic Test pulse oximetry 1 2020-05-26
Drug pyridostigmine bromide 1 2020-04-09
Device q-nrg metobolic cart device 1 2020-04-14
Dietary Supplement quercetin 1 2020-05-01
Drug r tablets 1 2020-03-25
Radiation radiological 1 2020-05-04
Diagnostic Test rapid salivary test 1 2020-04-15
Drug ravulizumab 1 2020-05-08
Drug recombinant human interferon î±2b spray 1 2020-02-14
Other rehabilitation 1 2020-04-26
Biological remestemcel-l 1 2020-04-28
Behavioral remote cognitive behavioral therapy for insomnia 1 2020-05-28
Biological respiratory tract sample 1 2020-04-28
Drug rhace2 1 2020-04-01
Diagnostic Test rhinopharyngeal 1 2020-03-20
Drug ribavirin 1 2020-02-11
Drug ritonavir/oseltamivir 1 2020-02-04
Drug roactemra 1 2020-03-24
Procedure robot assisted percutaneous cardiovascular intervention 1 2020-04-27
Biological rph-104 1 2020-05-06
Drug rtb101 1 2020-05-28
Biological saline containing 1% human serum albumin(solution of msc) 1 2020-02-24
Other saline with baby shampoo nasal irrigation 1 2020-04-11
Drug saline/standard care 1 2020-03-14
Diagnostic Test sample collection 1 2020-04-30
Diagnostic Test sample collection/performance evaluation (a) 1 2020-04-30
Diagnostic Test sample collection/performance evaluation (b) 1 2020-04-30
Drug sargramostim 1 2020-03-24
Other sars-cov-2 infection 1 2020-04-03
Biological sars-cov-2 rs 1 2020-04-24
Behavioral self-compassion for chronic pain virtual group treatment program 1 2020-05-21
Behavioral self-help booklet 1 2020-05-26
Behavioral self-questionnary 1 2020-05-27
Other self supportive care (ssc) 1 2020-06-01
Other self supportive care (ssc) alone 1 2020-06-01
Drug selinexor 1 2020-04-14
Other serum 1 2020-04-22
Biological serum test 1 2020-04-24
Drug sildenafil citrate 1 2020-02-14
Drug simvastatin 1 2020-04-13
Drug sirukumab 1 2020-05-07
Dietary Supplement sivomixx 1 2020-04-22
Device sledd with a l-mod 1 2020-04-07
Device smf 1 2020-05-08
Behavioral sms message support 1 2020-05-26
Drug sndx-6352 1 2020-05-29
Drug sodium bicarbonate 1 2020-05-02
Other spin-chat program 1 2020-04-01
Drug standard care. control arm will receive standard care. 1 2020-05-05
Other standard interface 1 2020-04-08
Procedure stellate ganglion block 1 2020-05-22
Biological stool collection 1 2020-04-28
Drug sulfamethoxazole 1 2020-04-20
Other supportive care 1 2020-04-14
Other surgical facial mask 1 2020-04-02
Behavioral survey 1 2020-04-28
Other suspension 1 2020-04-07
Drug suspension of heat killed (autoclaved) mycobacterium w 1 2020-03-31
Other suspension/maintenance of angiotensin receptor blockers/angiotensin-converting enzyme inhibitors 1 2020-04-07
Biological swab 1 2020-04-28
Drug symbicort 1 2020-03-29
Biological t cell derived exosom 1 2020-05-12
Drug t3 solution 1 2020-04-09
Drug tacrolimus 1 2020-04-07
Drug tazobactam 1 2020-05-15
Device tcc-covid mhealth 1 2020-05-21
Drug td-0903 1 2020-04-14
Behavioral tele-interventions related to diabetes management 1 2020-04-07
Behavioral tele-interventions related to diabetes management/mental well-being 1 2020-04-07
Procedure telephone follow-up 1 2020-04-14
Drug telmisartan 1 2020-04-17
Drug tenofovir disoproxil 1 2020-04-02
Drug tetrandrine 1 2020-03-04
Behavioral therapy intervention 1 2020-05-06
Drug thiazide 1 2020-03-30
Drug thiazide-like diuretics 1 2020-03-30
Drug thiazide/thiazide-like diuretics 1 2020-03-30
Drug thromboprophylaxis 1 2020-04-10
Drug thymosin 1 2020-03-21
Drug tirofiban 1 2020-04-23
Drug tj003234 1 2020-04-04
Drug tociliuzumab 1 2020-04-21
Procedure tracheotomy 1 2020-05-24
Drug tradipitant 1 2020-03-26
Drug traditional chinese medicine 1 2020-01-28
Drug treatment 1 2020-03-05
Drug treatment/prophylaxis 1 2020-03-05
Drug tridecactide 1 2020-04-30
Drug trimethoprim 1 2020-04-20
Drug trimethoprim/sulfamethoxazole 1 2020-04-20
Procedure tsvf 1 2020-03-26
Drug umifenovir 1 2020-04-14
Biological upper respiratory sample 1 2020-04-28
Other usual antibiotic treatment 1 2020-04-02
Behavioral usual care positioning with no instructions 1 2020-04-24
Drug usual practice / symbicort rapihaler 1 2020-03-29
Biological utooth btc) 1 2020-03-28
Drug uttr1147a 1 2020-05-11
Biological v-sars 1 2020-04-29
Drug verapamil 1 2020-04-14
Drug veru-111 1 2020-05-13
Behavioral virtual group intervention 1 2020-05-29
Dietary Supplement viusid 1 2020-05-25
Dietary Supplement viusid/asbrip 1 2020-05-25
Device volatile organic compounds analysis 1 2020-04-28
Device vv-ecmo 1 2020-03-25
Device vv-ecmo / cytokine adsorption 1 2020-03-25
Drug water 1 2020-02-04
Other weekly assessment 1 2020-04-07
Behavioral who recommendations (waiting condition) 1 2020-03-26
Drug xcel-umc-beta 1 2020-05-07
Other yoga 1 2020-05-31
Drug zidovudine 1 2020-04-08
Drug zithromax 1 2020-04-08

Interventions over Time

Weekly studies for each intervention

Studies by Country

Country Study_Count
United States 196
France 63
China 54
Spain 33
Italy 28
Canada 22
Mexico 18
Iran, Islamic Republic of 15
United Kingdom 13
Brazil 12
Russian Federation 10
Denmark 9
Germany 9
Greece 9
Turkey 9
Belgium 8
Pakistan 7
Netherlands 6
Switzerland 6
Argentina 5
Israel 5
Poland 5
Sweden 5
Egypt 4
Hong Kong 4
India 4
Saudi Arabia 4
Australia 3
Norway 3
Austria 2
Bangladesh 2
Chile 2
United States|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Netherlands|Singapore|Spain|Sweden|Switzerland|Taiwan|United Kingdom 2
United States|Germany|Spain|United Kingdom 2
Argentina|Canada|Chile|France|Germany|Israel|Italy|Japan|Russian Federation|Spain 1
Austria|Denmark|Germany 1
Austria|Germany 1
Bahrain 1
Belarus 1
Belgium|France|Monaco 1
Bosnia and Herzegovina 1
Canada|Mongolia 1
China|Italy 1
Czechia 1
Denmark|Germany|Hungary 1
Ecuador 1
France|Luxembourg 1
France|Monaco 1
French Guiana 1
Germany|Sweden 1
Gibraltar 1
Hungary 1
Iceland 1
Indonesia 1
Iraq 1
Ireland 1
Jordan 1
Korea, Republic of 1
North Macedonia 1
Puerto Rico 1
Romania 1
Singapore 1
Slovenia 1
South Africa 1
Taiwan 1
Thailand 1
Tunisia 1
United States|Austria|France|Israel|Spain|United Kingdom 1
United States|Brazil|Canada|Mexico 1
United States|Canada 1
United States|Canada|Denmark|France|Germany|Italy|Netherlands|Spain|United Kingdom 1
United States|Canada|Spain 1
United States|Denmark|Germany|Greece|Japan|Korea, Republic of|Mexico|Singapore|Spain|United Kingdom 1
United States|Israel 1
United States|Japan|Korea, Republic of|Mexico|Singapore 1
United States|Puerto Rico 1
United States|Spain 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 401
2 67
3 23
4 21
5 10
6 14
7 10
8 10
9 10
10 4
11 1
12 8
13 1
14 5
15 5
16 2
17 1
18 1
20 1
21 2
22 1
24 3
25 2
26 1
27 1
28 3
31 1
32 1
33 1
34 1
40 2
47 1
52 1
60 2
62 1
63 1
68 1
183 1
184 1

Phase

Phase Study_Count
N/A 197
Phase 2 167
Phase 3 103
Phase 2/Phase 3 42
Phase 4 40
Phase 1/Phase 2 33
Phase 1 30
Early Phase 1 11

Number of Arms

Number_of_Arms Count_of_Studies
1 120
2 385
3 56
4 39
5 4
6 6
7 1
8 2
9 2
11 1
13 1
17 1
21 1
NA 4

Number of Updates

Count of Versions Count of Studies
1 172
2 197
3 117
4 68
5 26
6 14
7 11
8 9
10 3
11 2
13 1
18 2
19 1

Update History Change Type

Change Type Count_of_Changes Count_of_Studies ratio
Study Status 1049 451 2.325942
Contacts/Locations 641 344 1.863372
None (earliest Version on record) 623 623 1.000000
Recruitment Status 344 315 1.092064
Outcome Measures 235 178 1.320225
Oversight 213 203 1.049261
Eligibility 211 154 1.370130
Study Identification 177 146 1.212329
Study Description 172 138 1.246377
Arms 139 112 1.241071
Interventions 139 112 1.241071
Study Design 132 105 1.257143
Sponsor/Collaborators 72 62 1.161290
Conditions 59 53 1.113207
IPDSharing 20 20 1.000000
References 18 17 1.058823
Documents 5 4 1.250000

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 10.00000 4.000 5.0000 5.0000 5.0000 12.000 10.0000 10.0
1st Qu. 10.00000 41.000 21.7500 20.0000 60.0000 120.000 240.0000 75.0
Median 60.00000 100.000 40.0000 50.0000 120.0000 335.000 462.0000 175.0
Mean 62.72727 5676.858 307.0667 168.2424 217.3713 818.881 993.1942 449.4
3rd Qu. 100.00000 314.000 97.5000 144.0000 229.0000 518.000 1185.0000 525.5
Max. 150.00000 506517.000 7600.0000 1090.0000 2900.0000 12000.000 10078.0000 2414.0

Trial Group Type

group_type Group_Count
Experimental 748
Active Comparator 220
Placebo Comparator 185
No Intervention 145
Other 70
Sham Comparator 5
NA 4

Intervention Model

intervention_model Study_Count
Parallel Assignment 451
Single Group Assignment 135
Sequential Assignment 17
Crossover Assignment 10
Factorial Assignment 10

Primary Purpose

primary_purpose Study_Count
Treatment 441
Prevention 72
Diagnostic 31
Other 31
Supportive Care 30
Health Services Research 12
Basic Science 3
Screening 2
Device Feasibility 1

Vaccines

nct_id brief_title link
NCT04276896 Immunity and Safety of Covid-19 Synthetic Minigene Vaccine https://ClinicalTrials.gov/show/NCT04276896
NCT04283461 Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04283461
NCT04299724 Safety and Immunity of Covid-19 aAPC Vaccine https://ClinicalTrials.gov/show/NCT04299724
NCT04313127 Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults https://ClinicalTrials.gov/show/NCT04313127
NCT04324606 A Study of a Candidate COVID-19 Vaccine (COV001) https://ClinicalTrials.gov/show/NCT04324606
NCT04336410 Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04336410
NCT04341389 A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) https://ClinicalTrials.gov/show/NCT04341389
NCT04352608 Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04352608
NCT04368988 Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant https://ClinicalTrials.gov/show/NCT04368988
NCT04368728 Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04368728
NCT04380532 Tableted COVID-19 Therapeutic Vaccine https://ClinicalTrials.gov/show/NCT04380532
NCT04380701 A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults https://ClinicalTrials.gov/show/NCT04380701
NCT04405076 Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older https://ClinicalTrials.gov/show/NCT04405076
NCT04412538 Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 https://ClinicalTrials.gov/show/NCT04412538

Phase

phase Study_Count
Phase 1 6
Phase 1/Phase 2 6
Phase 2 2

Country

country Study_Count
Australia 1
Canada 1
China 6
Germany 1
Mongolia 1
United Kingdom 1
United States 4

Site Count

Site_count Study_Count
1 6
2 2
3 3
5 1
6 1
10 1

Arms

number_of_arms Study_Count
1 3
3 3
4 2
5 1
6 1
8 1
9 1
13 1
21 1

Enrollment

Measure Vaccine
Min 20.0
1st Qu 111.0
Median 177.5
Mean 887.0
3rd Qu 708.0
Max 7600.0

Model

intervention_model Study_Count
Crossover Assignment 1
Parallel Assignment 4
Sequential Assignment 6
Single Group Assignment 3

Group Types

group_type Group_Count
Experimental 67
Placebo Comparator 9
Active Comparator 6

Update Count

Count of Versions Count of Studies
1 2
2 3
3 2
4 3
5 2
8 1
10 1

Change Type

Change Type Count_of_Changes Count_of_Studies ratio
Study Status 40 12 3.333333
Contacts/Locations 22 10 2.200000
None (earliest Version on record) 14 14 1.000000
Study Design 12 6 2.000000
Recruitment Status 11 8 1.375000
Study Identification 11 7 1.571429
Arms 10 5 2.000000
Eligibility 10 4 2.500000
Interventions 10 5 2.000000
Study Description 7 3 2.333333
Oversight 6 6 1.000000
Conditions 5 2 2.500000
Outcome Measures 4 3 1.333333
Sponsor/Collaborators 4 4 1.000000
IPDSharing 1 1 1.000000
References 1 1 1.000000

Observational Studies

Studies by Country

Country Study_Count
France 127
United States 74
Italy 36
China 31
United Kingdom 25
Egypt 23
Spain 22
Turkey 18
Germany 15
Switzerland 15
Belgium 11
Denmark 10
Austria 7
Canada 7
India 7
Norway 7
Hong Kong 6
Brazil 4
Sweden 4
Argentina 3
Israel 3
France|French Guiana 2
Luxembourg 2
Monaco 2
Netherlands 2
Poland 2
Portugal 2
Singapore 2
Algeria 1
Australia 1
Australia|Canada|China|France|Gambia|Germany|Israel|Italy|Malaysia|Poland|Portugal|Romania|Singapore|Switzerland 1
Austria|Belgium|Czechia|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Lithuania|Netherlands|Poland|Portugal|Russian Federation|Spain|Sweden|Switzerland|United Kingdom 1
Belgium|Italy|United Kingdom 1
Brazil|Chile|Uruguay 1
Colombia 1
Croatia 1
Czechia 1
Denmark|France|Germany|Norway 1
Ecuador 1
Finland|France|Germany|Italy|Sweden|United Kingdom 1
France|Guadeloupe|Martinique 1
France|Martinique 1
Germany|Romania 1
Greece 1
Hungary 1
Iran, Islamic Republic of 1
Italy|Romania|United Kingdom 1
Italy|San Marino 1
Jordan 1
Korea, Republic of 1
Mexico 1
Pakistan 1
Russian Federation 1
Slovenia 1
United States|Albania|Australia|Czechia|France|Germany|Hong Kong|Israel|Italy|Lebanon|Norway|Poland|Spain|Sweden|Taiwan 1
United States|Argentina|Australia|Bolivia|Chile|Costa Rica|Czechia|Germany|Guatemala|Italy|Lebanon|Mexico|Netherlands|Nigeria|Puerto Rico|Saudi Arabia|Spain|Tunisia|Turkey|Venezuela 1
United States|Egypt|Germany|Peru|Singapore 1
United States|Egypt|Iran, Islamic Republic of 1
United States|Peru 1
United States|United Kingdom 1

Sites per Study

Site_count Study_Count
1 406
2 28
3 15
4 3
5 10
6 5
7 5
8 3
9 3
10 1
11 2
12 1
13 1
14 1
16 1
17 3
19 2
20 1
21 1
23 1
27 1
34 1
41 1
69 1
81 1
97 1
128 1
324 1

Number of Updates

Count of Versions Count of Studies
1 234
2 166
3 52
4 27
5 8
6 3
7 3
9 2
10 1
11 1
15 1
22 1
34 1
40 1

Update History Change Type

Change Type Count_of_Changes Count_of_Studies ratio
Study Status 558 267 2.089888
None (earliest Version on record) 501 501 1.000000
Contacts/Locations 200 156 1.282051
Recruitment Status 130 120 1.083333
Study Description 104 88 1.181818
Outcome Measures 99 87 1.137931
Study Identification 98 89 1.101124
Oversight 64 61 1.049180
Eligibility 59 50 1.180000
Study Design 53 51 1.039216
Sponsor/Collaborators 37 34 1.088235
Groups 33 28 1.178571
Interventions 33 28 1.178571
Conditions 31 29 1.068966
References 11 11 1.000000
IPDSharing 3 3 1.000000

Enrollment Metrics

Measure Observational
Min 5.0
1st Qu 100.0
Median 345.0
Mean 38589.8
3rd Qu 1000.0
Max 10000000.0

Observation Model

observational_model Study_Count
Cohort 314
Case-Only 66
Other 51
Case-Control 40
Ecologic or Community 20
Family-Based 5
Case-Crossover 4
NA 1

Time Perspective

time_perspective Study_Count
Prospective 304
Retrospective 104
Cross-Sectional 56
Other 36
NA 1

Registries

Studies by Country

Country Study_Count
France 15
United States 14
Spain 10
Italy 8
Turkey 7
Belgium 5
Germany 5
China 3
Denmark 3
Switzerland 3
Austria 2
Mexico 2
Norway 2
United Kingdom 2
Bangladesh 1
Canada 1
Egypt 1
Hungary 1
Netherlands 1
Poland 1
Russian Federation 1
Sweden 1
Tunisia 1
Ukraine 1
United States|Brazil|Colombia|France|Spain 1
United States|Poland 1

Sites per Study

Site_count Study_Count
1 74
2 7
3 1
4 1
6 1
7 1
11 1
15 1
17 1
18 1
37 1
39 1
61 1
75 1

Number of Updates

Count of Versions Count of Studies
1 40
2 28
3 19
4 4
5 1
11 1

Update History Change Type

Change Type Count_of_Changes Count_of_Studies ratio
None (earliest Version on record) 93 93 1.000000
Study Status 92 53 1.735849
Contacts/Locations 47 28 1.678571
Recruitment Status 22 21 1.047619
Study Design 18 16 1.125000
Outcome Measures 17 15 1.133333
Study Description 17 15 1.133333
Study Identification 17 16 1.062500
Eligibility 9 9 1.000000
Oversight 9 9 1.000000
Groups 7 7 1.000000
Interventions 7 7 1.000000
Conditions 5 5 1.000000
Sponsor/Collaborators 5 5 1.000000
References 3 3 1.000000
Documents 2 2 1.000000
IPDSharing 2 2 1.000000
Results 1 1 1.000000

Enrollment Metrics

Measure Registries
Min 10.00
1st Qu 100.00
Median 300.00
Mean 37637.91
3rd Qu 1000.00
Max 3000000.00

Registry Model

observational_model Study_Count
Cohort 67
Case-Control 13
Case-Only 8
Other 4
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 71
Other 14
Cross-Sectional 8

Follow-up

target_duration Study_Count
1 Year 12
1 Month 11
12 Months 10
3 Months 9
6 Months 9
2 Months 6
2 Years 4
4 Weeks 4
1 Day 3
30 Days 3
20 Years 2
28 Days 2
3 Weeks 2
5 Years 2
10 Days 1
14 Weeks 1
18 Months 1
2 Weeks 1
20 Days 1
20 Months 1
24 Months 1
6 Weeks 1
60 Days 1
7 Days 1
7 Months 1
8 Weeks 1
9 Months 1
9 Weeks 1

Overview of trials

Interventional Trials

nct_id brief_title link
NCT04244591 Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure https://ClinicalTrials.gov/show/NCT04244591
NCT04252118 Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04252118
NCT04251871 Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection https://ClinicalTrials.gov/show/NCT04251871
NCT04252274 Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04252274
NCT04252885 The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection https://ClinicalTrials.gov/show/NCT04252885
NCT04263402 The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia https://ClinicalTrials.gov/show/NCT04263402
NCT04255017 A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04255017
NCT04254874 A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04254874
NCT04264533 Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia https://ClinicalTrials.gov/show/NCT04264533
NCT04261270 A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04261270
NCT04331613 Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS https://ClinicalTrials.gov/show/NCT04331613
NCT04275245 Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04275245
NCT04261517 Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04261517
NCT04269525 Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia https://ClinicalTrials.gov/show/NCT04269525
NCT04282902 A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection https://ClinicalTrials.gov/show/NCT04282902
NCT04276688 Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment https://ClinicalTrials.gov/show/NCT04276688
NCT04280224 NK Cells Treatment for COVID-19 https://ClinicalTrials.gov/show/NCT04280224
NCT04304313 A Pilot Study of Sildenafil in COVID-19 https://ClinicalTrials.gov/show/NCT04304313
NCT04275414 Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04275414
NCT04273763 Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19) https://ClinicalTrials.gov/show/NCT04273763
NCT04279197 Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With Fuzheng Huayu https://ClinicalTrials.gov/show/NCT04279197
NCT04273321 Efficacy and Safety of Corticosteroids in COVID-19 https://ClinicalTrials.gov/show/NCT04273321
NCT04276896 Immunity and Safety of Covid-19 Synthetic Minigene Vaccine https://ClinicalTrials.gov/show/NCT04276896
NCT04343794 Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19 https://ClinicalTrials.gov/show/NCT04343794
NCT04280705 Adaptive COVID-19 Treatment Trial (ACTT) https://ClinicalTrials.gov/show/NCT04280705
NCT04280588 Fingolimod in COVID-19 https://ClinicalTrials.gov/show/NCT04280588
NCT04283461 Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04283461
NCT04288102 Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019(COVID-19) https://ClinicalTrials.gov/show/NCT04288102
NCT04291729 Evaluation of Ganovo (Danoprevir ) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04291729
NCT04292730 Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment https://ClinicalTrials.gov/show/NCT04292730
NCT04292899 Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Severe Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04292899
NCT04308317 Tetrandrine Tablets Used in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04308317
NCT04304053 Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention https://ClinicalTrials.gov/show/NCT04304053
NCT04299724 Safety and Immunity of Covid-19 aAPC Vaccine https://ClinicalTrials.gov/show/NCT04299724
NCT04303507 Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting https://ClinicalTrials.gov/show/NCT04303507
NCT04306055 Blood Donor Recruitment During Epidemic of COVID-19 https://ClinicalTrials.gov/show/NCT04306055
NCT04310228 Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019 https://ClinicalTrials.gov/show/NCT04310228
NCT04305457 Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04305457
NCT04305106 Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT https://ClinicalTrials.gov/show/NCT04305106
NCT04304690 COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic https://ClinicalTrials.gov/show/NCT04304690
NCT04306393 Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 https://ClinicalTrials.gov/show/NCT04306393
NCT04308668 Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 https://ClinicalTrials.gov/show/NCT04308668
NCT04311177 Losartan for Patients With COVID-19 Not Requiring Hospitalization https://ClinicalTrials.gov/show/NCT04311177
NCT04316377 Norwegian Coronavirus Disease 2019 Study https://ClinicalTrials.gov/show/NCT04316377
NCT04315948 Trial of Treatments for COVID-19 in Hospitalized Adults https://ClinicalTrials.gov/show/NCT04315948
NCT04312009 Losartan for Patients With COVID-19 Requiring Hospitalization https://ClinicalTrials.gov/show/NCT04312009
NCT04315480 Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis https://ClinicalTrials.gov/show/NCT04315480
NCT04311697 Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure https://ClinicalTrials.gov/show/NCT04311697
NCT04315298 Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04315298
NCT04313322 Treatment of COVID-19 Patients Using Wharton’s Jelly-Mesenchymal Stem Cells https://ClinicalTrials.gov/show/NCT04313322
NCT04313127 Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults https://ClinicalTrials.gov/show/NCT04313127
NCT04313023 The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04313023
NCT04312997 The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04312997
NCT04323514 Use of Ascorbic Acid in Patients With COVID 19 https://ClinicalTrials.gov/show/NCT04323514
NCT04321174 COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir https://ClinicalTrials.gov/show/NCT04321174
NCT04315896 Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) https://ClinicalTrials.gov/show/NCT04315896
NCT04323527 Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 https://ClinicalTrials.gov/show/NCT04323527
NCT04320056 Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19) https://ClinicalTrials.gov/show/NCT04320056
NCT04318015 Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) https://ClinicalTrials.gov/show/NCT04318015
NCT04317092 Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) https://ClinicalTrials.gov/show/NCT04317092
NCT04317040 CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment https://ClinicalTrials.gov/show/NCT04317040
NCT04324606 A Study of a Candidate COVID-19 Vaccine (COV001) https://ClinicalTrials.gov/show/NCT04324606
NCT04319900 Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia https://ClinicalTrials.gov/show/NCT04319900
NCT04319445 Mindfulness During COVID-19 https://ClinicalTrials.gov/show/NCT04319445
NCT04318444 Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04318444
NCT04318431 Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children https://ClinicalTrials.gov/show/NCT04318431
NCT04325867 Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19 https://ClinicalTrials.gov/show/NCT04325867
NCT04320953 Non-contact Endoscopy at Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04320953
NCT04320238 Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff https://ClinicalTrials.gov/show/NCT04320238
NCT04319731 A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure https://ClinicalTrials.gov/show/NCT04319731
NCT04328961 Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP) https://ClinicalTrials.gov/show/NCT04328961
NCT04328129 Household Transmission Investigation Study for COVID-19 in French Guiana https://ClinicalTrials.gov/show/NCT04328129
NCT04323345 Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus https://ClinicalTrials.gov/show/NCT04323345
NCT04322682 Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) https://ClinicalTrials.gov/show/NCT04322682
NCT04322396 Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04322396
NCT04322344 Escin in Patients With Covid-19 Infection https://ClinicalTrials.gov/show/NCT04322344
NCT04321616 The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients https://ClinicalTrials.gov/show/NCT04321616
NCT04321278 Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II) https://ClinicalTrials.gov/show/NCT04321278
NCT04321096 The Impact of Camostat Mesilate on COVID-19 Infection https://ClinicalTrials.gov/show/NCT04321096
NCT04321421 Hyperimmune Plasma for Critical Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04321421
NCT04320615 A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04320615
NCT04330690 Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial https://ClinicalTrials.gov/show/NCT04330690
NCT04327349 Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial https://ClinicalTrials.gov/show/NCT04327349
NCT04326920 Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC) https://ClinicalTrials.gov/show/NCT04326920
NCT04322773 Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure https://ClinicalTrials.gov/show/NCT04322773
NCT04322565 Colchicine Counteracting Inflammation in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04322565
NCT04321993 Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04321993
NCT04322123 Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19) https://ClinicalTrials.gov/show/NCT04322123
NCT04371601 Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04371601
NCT04353271 Trial of Hydroxychloroquine In Covid-19 Kinetics https://ClinicalTrials.gov/show/NCT04353271
NCT04336462 Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04336462
NCT04327206 BCG Vaccination to Protect Healthcare Workers Against COVID-19 https://ClinicalTrials.gov/show/NCT04327206
NCT04326452 Treating COVID-19 With a Bidirectional Oxygenation Valve https://ClinicalTrials.gov/show/NCT04326452
NCT04325893 Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease https://ClinicalTrials.gov/show/NCT04325893
NCT04325061 Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04325061
NCT04324996 A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19 https://ClinicalTrials.gov/show/NCT04324996
NCT04324528 Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation https://ClinicalTrials.gov/show/NCT04324528
NCT04324489 DAS181 for Severe COVID-19: Compassionate Use https://ClinicalTrials.gov/show/NCT04324489
NCT04324463 Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial https://ClinicalTrials.gov/show/NCT04324463
NCT04324073 Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI https://ClinicalTrials.gov/show/NCT04324073
NCT04324021 Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. https://ClinicalTrials.gov/show/NCT04324021
NCT04328285 Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers https://ClinicalTrials.gov/show/NCT04328285
NCT04327505 Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04327505
NCT04355962 Sevoflurane in COVID-19 ARDS (SevCov) https://ClinicalTrials.gov/show/NCT04355962
NCT04329533 Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04329533
NCT04326790 The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention https://ClinicalTrials.gov/show/NCT04326790
NCT04326426 ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection https://ClinicalTrials.gov/show/NCT04326426
NCT04326036 Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection https://ClinicalTrials.gov/show/NCT04326036
NCT04325906 Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS https://ClinicalTrials.gov/show/NCT04325906
NCT04324190 DIgital Online SuPport for COVID-19 StrEss https://ClinicalTrials.gov/show/NCT04324190
NCT04327388 Sarilumab COVID-19 https://ClinicalTrials.gov/show/NCT04327388
NCT04327401 COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III https://ClinicalTrials.gov/show/NCT04327401
NCT04344379 Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus https://ClinicalTrials.gov/show/NCT04344379
NCT04331899 Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19 https://ClinicalTrials.gov/show/NCT04331899
NCT04328467 Pre-exposure Prophylaxis for SARS-Coronavirus-2 https://ClinicalTrials.gov/show/NCT04328467
NCT04328441 Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine https://ClinicalTrials.gov/show/NCT04328441
NCT04328012 COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04328012
NCT04328493 The Vietnam Chloroquine Treatment on COVID-19 https://ClinicalTrials.gov/show/NCT04328493
NCT04336254 Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04336254
NCT04329195 ACE Inhibitors or ARBs Discontinuation in Context of SARS-CoV-2 Pandemic https://ClinicalTrials.gov/show/NCT04329195
NCT04333368 Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS https://ClinicalTrials.gov/show/NCT04333368
NCT04331054 Protective Role of Inhaled Steroids for Covid-19 Infection https://ClinicalTrials.gov/show/NCT04331054
NCT04329611 ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease https://ClinicalTrials.gov/show/NCT04329611
NCT04348370 BCG Vaccine for Health Care Workers as Defense Against COVID 19 https://ClinicalTrials.gov/show/NCT04348370
NCT04332107 Azithromycin for COVID-19 Treatment in Outpatients Nationwide https://ClinicalTrials.gov/show/NCT04332107
NCT04331600 Chloroquine as Antiviral Treatment in Coronavirus Infection 2020 https://ClinicalTrials.gov/show/NCT04331600
NCT04331470 Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04331470
NCT04330300 Coronavirus (COVID-19) ACEi/ARB Investigation https://ClinicalTrials.gov/show/NCT04330300
NCT04329923 The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) https://ClinicalTrials.gov/show/NCT04329923
NCT04328480 The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients. https://ClinicalTrials.gov/show/NCT04328480
NCT04329832 Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19 https://ClinicalTrials.gov/show/NCT04329832
NCT04376515 Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19) https://ClinicalTrials.gov/show/NCT04376515
NCT04352348 Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being https://ClinicalTrials.gov/show/NCT04352348
NCT04347174 A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients https://ClinicalTrials.gov/show/NCT04347174
NCT04342182 Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study) https://ClinicalTrials.gov/show/NCT04342182
NCT04336332 Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19 https://ClinicalTrials.gov/show/NCT04336332
NCT04335123 Study of Open Label Losartan in COVID-19 https://ClinicalTrials.gov/show/NCT04335123
NCT04333355 Safety in Convalescent Plasma Transfusion to COVID-19 https://ClinicalTrials.gov/show/NCT04333355
NCT04332094 Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04332094
NCT04331808 CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI) https://ClinicalTrials.gov/show/NCT04331808
NCT04331366 Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19 https://ClinicalTrials.gov/show/NCT04331366
NCT04330638 Treatment of COVID-19 Patients With Anti-interleukin Drugs https://ClinicalTrials.gov/show/NCT04330638
NCT04329650 Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04329650
NCT04343651 Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04343651
NCT04335305 Checkpoint Blockade in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04335305
NCT04332991 Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease https://ClinicalTrials.gov/show/NCT04332991
NCT04339712 Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction https://ClinicalTrials.gov/show/NCT04339712
NCT04338009 Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04338009
NCT04335279 Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program https://ClinicalTrials.gov/show/NCT04335279
NCT04335136 Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04335136
NCT04335097 Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation https://ClinicalTrials.gov/show/NCT04335097
NCT04334265 Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019 https://ClinicalTrials.gov/show/NCT04334265
NCT04334044 Treatment of SARS Caused by COVID-19 With Ruxolitinib https://ClinicalTrials.gov/show/NCT04334044
NCT04333914 Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04333914
NCT04333589 Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive https://ClinicalTrials.gov/show/NCT04333589
NCT04333550 Application of Desferal to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04333550
NCT04333420 Open-label, Randomized Study of IFX-1 in Patients With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04333420
NCT04333407 Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial. https://ClinicalTrials.gov/show/NCT04333407
NCT04333225 Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers https://ClinicalTrials.gov/show/NCT04333225
NCT04331834 Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04331834
NCT04331795 Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis https://ClinicalTrials.gov/show/NCT04331795
NCT04347226 Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04347226
NCT04345523 Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04345523
NCT04340349 Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals https://ClinicalTrials.gov/show/NCT04340349
NCT04339660 Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04339660
NCT04337541 Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System https://ClinicalTrials.gov/show/NCT04337541
NCT04335786 Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease https://ClinicalTrials.gov/show/NCT04335786
NCT04335071 Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04335071
NCT04334928 Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel https://ClinicalTrials.gov/show/NCT04334928
NCT04334850 Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04334850
NCT04334460 Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects https://ClinicalTrials.gov/show/NCT04334460
NCT04334382 Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 https://ClinicalTrials.gov/show/NCT04334382
NCT04334629 LIBERATE Trial in COVID-19 https://ClinicalTrials.gov/show/NCT04334629
NCT04348409 Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04348409
NCT04343053 Pro-thrombotic Status in Patients With SARS-Cov-2 Infection https://ClinicalTrials.gov/show/NCT04343053
NCT04340544 Hydroxychloroquine for the Treatment of Mild COVID-19 Disease https://ClinicalTrials.gov/show/NCT04340544
NCT04337008 Renin Angiotensin System - CoronaVirus https://ClinicalTrials.gov/show/NCT04337008
NCT04336904 Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19 https://ClinicalTrials.gov/show/NCT04336904
NCT04336774 CAPTION AI to Minimize Risk of COVID Exposure https://ClinicalTrials.gov/show/NCT04336774
NCT04335552 Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04335552
NCT04336410 Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04336410
NCT04342650 Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection https://ClinicalTrials.gov/show/NCT04342650
NCT04341116 Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04341116
NCT04338568 Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study https://ClinicalTrials.gov/show/NCT04338568
NCT04345861 Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial) https://ClinicalTrials.gov/show/NCT04345861
NCT04341675 Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04341675
NCT04338828 Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED https://ClinicalTrials.gov/show/NCT04338828
NCT04338841 HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04338841
NCT04343092 Efficacy of Ivermectin as Add on Therapy in COVID19 Patients https://ClinicalTrials.gov/show/NCT04343092
NCT04349631 A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 https://ClinicalTrials.gov/show/NCT04349631
NCT04346797 CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort https://ClinicalTrials.gov/show/NCT04346797
NCT04337918 Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection https://ClinicalTrials.gov/show/NCT04337918
NCT04344951 Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT04344951
NCT04340557 Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04340557
NCT04339816 Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial https://ClinicalTrials.gov/show/NCT04339816
NCT04384380 Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04384380
NCT04364893 Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19 https://ClinicalTrials.gov/show/NCT04364893
NCT04361552 Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection) https://ClinicalTrials.gov/show/NCT04361552
NCT04353674 Modulation of Hyperinflammation in COVID-19 https://ClinicalTrials.gov/show/NCT04353674
NCT04352933 PROLIFIC ChemoprophylaxisTrial (COVID-19) https://ClinicalTrials.gov/show/NCT04352933
NCT04347031 A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19 https://ClinicalTrials.gov/show/NCT04347031
NCT04346147 Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 https://ClinicalTrials.gov/show/NCT04346147
NCT04345848 Preventing COVID-19 Complications With Low- and High-dose Anticoagulation https://ClinicalTrials.gov/show/NCT04345848
NCT04345614 A Study of CM4620-Injectable Emulsion (IE) in Patients With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04345614
NCT04344210 Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus https://ClinicalTrials.gov/show/NCT04344210
NCT04342169 University of Utah COVID-19 Hydrochloroquine Trial https://ClinicalTrials.gov/show/NCT04342169
NCT04341493 Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04341493
NCT04341441 Will Hydroxychloroquine Impede or Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04341441
NCT04341415 Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome https://ClinicalTrials.gov/show/NCT04341415
NCT04341389 A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) https://ClinicalTrials.gov/show/NCT04341389
NCT04341038 Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury https://ClinicalTrials.gov/show/NCT04341038
NCT04340050 COVID-19 Convalescent Plasma https://ClinicalTrials.gov/show/NCT04340050
NCT04339426 Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection https://ClinicalTrials.gov/show/NCT04339426
NCT04338958 Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation https://ClinicalTrials.gov/show/NCT04338958
NCT04341922 A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04341922
NCT04358081 Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease https://ClinicalTrials.gov/show/NCT04358081
NCT04350580 Polyvalent Immunoglobulin in COVID-19 Related ARds https://ClinicalTrials.gov/show/NCT04350580
NCT04348383 Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19. https://ClinicalTrials.gov/show/NCT04348383
NCT04347681 Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19 https://ClinicalTrials.gov/show/NCT04347681
NCT04346693 An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19 https://ClinicalTrials.gov/show/NCT04346693
NCT04346420 Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19 https://ClinicalTrials.gov/show/NCT04346420
NCT04345653 Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers https://ClinicalTrials.gov/show/NCT04345653
NCT04344587 Awake Prone Position for Early Hypoxemia in COVID-19 https://ClinicalTrials.gov/show/NCT04344587
NCT04344457 Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 https://ClinicalTrials.gov/show/NCT04344457
NCT04344236 Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04344236
NCT04344106 Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study https://ClinicalTrials.gov/show/NCT04344106
NCT04343768 An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT04343768
NCT04343755 Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04343755
NCT04343261 Convalescent Plasma in the Treatment of COVID 19 https://ClinicalTrials.gov/show/NCT04343261
NCT04342728 Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation https://ClinicalTrials.gov/show/NCT04342728
NCT04342663 A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04342663
NCT04342221 Hydroxychloroquine for COVID-19 https://ClinicalTrials.gov/show/NCT04342221
NCT04341207 Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients https://ClinicalTrials.gov/show/NCT04341207
NCT04343248 Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF) https://ClinicalTrials.gov/show/NCT04343248
NCT04341142 Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER https://ClinicalTrials.gov/show/NCT04341142
NCT04353037 PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine https://ClinicalTrials.gov/show/NCT04353037
NCT04351906 Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04351906
NCT04347980 Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19 https://ClinicalTrials.gov/show/NCT04347980
NCT04346615 Safety and Efficacy Trial of Vazegepant Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen https://ClinicalTrials.gov/show/NCT04346615
NCT04346589 Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients https://ClinicalTrials.gov/show/NCT04346589
NCT04344730 Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04344730
NCT04344431 Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04344431
NCT04344080 Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04344080
NCT04344041 COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial) https://ClinicalTrials.gov/show/NCT04344041
NCT04344015 COVID-19 Plasma Collection https://ClinicalTrials.gov/show/NCT04344015
NCT04343989 A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection https://ClinicalTrials.gov/show/NCT04343989
NCT04343963 Pyridostigmine in Severe SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04343963
NCT04343729 Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19 https://ClinicalTrials.gov/show/NCT04343729
NCT04348513 Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04348513
NCT04345692 A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04345692
NCT04390178 Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04390178
NCT04351724 Austrian CoronaVirus Adaptive Clinical Trial (COVID-19) https://ClinicalTrials.gov/show/NCT04351724
NCT04348929 Birth Experience During COVID-19 Confinement https://ClinicalTrials.gov/show/NCT04348929
NCT04345991 Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort https://ClinicalTrials.gov/show/NCT04345991
NCT04345549 Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04345549
NCT04344535 Convalescent Plasma vs. Standard Plasma for COVID-19 https://ClinicalTrials.gov/show/NCT04344535
NCT04344444 Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease https://ClinicalTrials.gov/show/NCT04344444
NCT04344288 Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection https://ClinicalTrials.gov/show/NCT04344288
NCT04344561 Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation https://ClinicalTrials.gov/show/NCT04344561
NCT04342897 A Study of LY3127804 in Participants With COVID-19 https://ClinicalTrials.gov/show/NCT04342897
NCT04345289 Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04345289
NCT04345276 Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04345276
NCT04344600 Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04344600
NCT04349410 The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol https://ClinicalTrials.gov/show/NCT04349410
NCT04348305 Hydrocortisone for COVID-19 and Severe Hypoxia https://ClinicalTrials.gov/show/NCT04348305
NCT04347538 Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04347538
NCT04347382 Honey & Nigella Sativa-COVID-Pakistan Trial Against COVID-19 https://ClinicalTrials.gov/show/NCT04347382
NCT04349371 Saved From COVID-19 https://ClinicalTrials.gov/show/NCT04349371
NCT04346355 Efficacy of Early Administration of Tocilizumab in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04346355
NCT04359251 Different PEEP Settings of COVID-19 Induced ARDS https://ClinicalTrials.gov/show/NCT04359251
NCT04355728 Use of UC-MSCs for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04355728
NCT04350281 Double Therapy With IFN-beta 1b and Hydroxychloroquine https://ClinicalTrials.gov/show/NCT04350281
NCT04348864 COVID-19 Antibody Self-testing Using Virtual Point-of-care https://ClinicalTrials.gov/show/NCT04348864
NCT04348695 Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19. https://ClinicalTrials.gov/show/NCT04348695
NCT04348656 CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) https://ClinicalTrials.gov/show/NCT04348656
NCT04346667 Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds https://ClinicalTrials.gov/show/NCT04346667
NCT04346017 Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome https://ClinicalTrials.gov/show/NCT04346017
NCT04357340 The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04357340
NCT04348500 Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease https://ClinicalTrials.gov/show/NCT04348500
NCT04347239 Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04347239
NCT04382391 Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms https://ClinicalTrials.gov/show/NCT04382391
NCT04361916 Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino) https://ClinicalTrials.gov/show/NCT04361916
NCT04357808 Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID) https://ClinicalTrials.gov/show/NCT04357808
NCT04357106 COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma https://ClinicalTrials.gov/show/NCT04357106
NCT04355143 Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19) https://ClinicalTrials.gov/show/NCT04355143
NCT04354831 A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04354831
NCT04354610 Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection https://ClinicalTrials.gov/show/NCT04354610
NCT04353596 Stopping ACE-inhibitors in COVID-19 https://ClinicalTrials.gov/show/NCT04353596
NCT04352608 Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04352608
NCT04351763 Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms https://ClinicalTrials.gov/show/NCT04351763
NCT04351620 High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19 https://ClinicalTrials.gov/show/NCT04351620
NCT04351542 Ayurveda for Flu Like Illness During Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04351542
NCT04351191 PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds https://ClinicalTrials.gov/show/NCT04351191
NCT04350736 First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19 https://ClinicalTrials.gov/show/NCT04350736
NCT04350684 Umifenovir in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04350684
NCT04350671 Interferon Beta 1a in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04350671
NCT04350593 Dapagliflozin in Respiratory Failure in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04350593
NCT04350320 Trial to Study the Benefit of Colchicine in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04350320
NCT04350073 Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID) https://ClinicalTrials.gov/show/NCT04350073
NCT04349228 Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals https://ClinicalTrials.gov/show/NCT04349228
NCT04349098 Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04349098
NCT04348435 A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 https://ClinicalTrials.gov/show/NCT04348435
NCT04347915 The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04347915
NCT04351581 Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04351581
NCT04346446 Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients https://ClinicalTrials.gov/show/NCT04346446
NCT04357327 Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04357327
NCT04356534 Convalescent Plasma Trial in COVID -19 Patients https://ClinicalTrials.gov/show/NCT04356534
NCT04355897 CoVID-19 Plasma in Treatment of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04355897
NCT04355637 Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia https://ClinicalTrials.gov/show/NCT04355637
NCT04355026 Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04355026
NCT04351516 Test and Treat COVID 65plus+ https://ClinicalTrials.gov/show/NCT04351516
NCT04351152 Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Hospitalized Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04351152
NCT04351243 A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE). https://ClinicalTrials.gov/show/NCT04351243
NCT04355364 Efficacy and Safety of Aerosolized Intra-tracheal Dornase Alfa Administration in Patients With COVID19-induced ARDS (COVIDORNASE) https://ClinicalTrials.gov/show/NCT04355364
NCT04367662 Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19 https://ClinicalTrials.gov/show/NCT04367662
NCT04361344 Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection https://ClinicalTrials.gov/show/NCT04361344
NCT04359264 Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT04359264
NCT04358939 Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19) https://ClinicalTrials.gov/show/NCT04358939
NCT04358549 Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19 https://ClinicalTrials.gov/show/NCT04358549
NCT04354870 COVID-19 PrEP HCW HCQ Study https://ClinicalTrials.gov/show/NCT04354870
NCT04354259 Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19 https://ClinicalTrials.gov/show/NCT04354259
NCT04353206 Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure https://ClinicalTrials.gov/show/NCT04353206
NCT04352751 Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020 https://ClinicalTrials.gov/show/NCT04352751
NCT04354428 Treatment for COVID-19 in High-Risk Adult Outpatients https://ClinicalTrials.gov/show/NCT04354428
NCT04361838 The COVID-19 ICU PRAYER Study https://ClinicalTrials.gov/show/NCT04361838
NCT04364009 Anakinra for COVID-19 Respiratory Symptoms https://ClinicalTrials.gov/show/NCT04364009
NCT04363853 Tocilizumab Treatment in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04363853
NCT04361942 Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV) https://ClinicalTrials.gov/show/NCT04361942
NCT04357782 Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation https://ClinicalTrials.gov/show/NCT04357782
NCT04356690 Etoposide in Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04356690
NCT04355247 Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm https://ClinicalTrials.gov/show/NCT04355247
NCT04373044 Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19 https://ClinicalTrials.gov/show/NCT04373044
NCT04356482 CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19 https://ClinicalTrials.gov/show/NCT04356482
NCT04355936 Telmisartan for Treatment of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04355936
NCT04377308 Fluoxetine to Reduce Intubation and Death After COVID19 Infection https://ClinicalTrials.gov/show/NCT04377308
NCT04357730 Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04357730
NCT04376034 Convalescent Plasma Collection and Treatment in Pediatrics and Adults https://ClinicalTrials.gov/show/NCT04376034
NCT04358614 Baricitinib Therapy in COVID-19 https://ClinicalTrials.gov/show/NCT04358614
NCT04368845 Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study https://ClinicalTrials.gov/show/NCT04368845
NCT04368156 Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms https://ClinicalTrials.gov/show/NCT04368156
NCT04366063 Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04366063
NCT04362332 Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19 https://ClinicalTrials.gov/show/NCT04362332
NCT04362085 Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care https://ClinicalTrials.gov/show/NCT04362085
NCT04359797 COVID-19 Patient Positioning Pragmatic Trial https://ClinicalTrials.gov/show/NCT04359797
NCT04359537 Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 https://ClinicalTrials.gov/show/NCT04359537
NCT04359277 A Randomized Trial of Anticoagulation Strategies in COVID-19 https://ClinicalTrials.gov/show/NCT04359277
NCT04357990 Kerecis Oral and Nasal Spray for Treating the Symptoms of COVID-19 https://ClinicalTrials.gov/show/NCT04357990
NCT04357366 suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) https://ClinicalTrials.gov/show/NCT04357366
NCT04358068 Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19 https://ClinicalTrials.gov/show/NCT04358068
NCT04374084 Moxibustion Plus Cupping in Convalescent Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04374084
NCT04359680 Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers https://ClinicalTrials.gov/show/NCT04359680
NCT04359901 Sarilumab for Patients With Moderate COVID-19 Disease https://ClinicalTrials.gov/show/NCT04359901
NCT04358003 Plasma Adsorption in Patients With Confirmed COVID-19 https://ClinicalTrials.gov/show/NCT04358003
NCT04362176 Passive Immunity Trial of Nashville II for COVID-19 https://ClinicalTrials.gov/show/NCT04362176
NCT04361526 Pilot Study on Cytokine Filtration in COVID-19 ARDS https://ClinicalTrials.gov/show/NCT04361526
NCT04359862 Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection https://ClinicalTrials.gov/show/NCT04359862
NCT04359810 Plasma Therapy of COVID-19 in Critically Ill Patients https://ClinicalTrials.gov/show/NCT04359810
NCT04359329 Estrogen Patch for COVID-19 Symptoms https://ClinicalTrials.gov/show/NCT04359329
NCT04358926 Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19) https://ClinicalTrials.gov/show/NCT04358926
NCT04358783 Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia https://ClinicalTrials.gov/show/NCT04358783
NCT04363736 A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04363736
NCT04413864 Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19 https://ClinicalTrials.gov/show/NCT04413864
NCT04366882 Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients https://ClinicalTrials.gov/show/NCT04366882
NCT04366089 Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora https://ClinicalTrials.gov/show/NCT04366089
NCT04365101 Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (CYNK-001-COVID-19) https://ClinicalTrials.gov/show/NCT04365101
NCT04364737 Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04364737
NCT04364594 COVID-19 Search in Conjunctival Cells https://ClinicalTrials.gov/show/NCT04364594
NCT04361474 Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity https://ClinicalTrials.gov/show/NCT04361474
NCT04361396 Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04361396
NCT04361214 Leflunomide in Mild COVID-19 Patients https://ClinicalTrials.gov/show/NCT04361214
NCT04360980 The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection https://ClinicalTrials.gov/show/NCT04360980
NCT04360837 PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients https://ClinicalTrials.gov/show/NCT04360837
NCT04360811 Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04360811
NCT04373200 Human Ab Response & immunoMONItoring of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04373200
NCT04366323 Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 https://ClinicalTrials.gov/show/NCT04366323
NCT04366245 Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04366245
NCT04362137 Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID) https://ClinicalTrials.gov/show/NCT04362137
NCT04377750 The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation https://ClinicalTrials.gov/show/NCT04377750
NCT04368793 Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge https://ClinicalTrials.gov/show/NCT04368793
NCT04368377 Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04368377
NCT04366947 Intravascular Access in Suspected/Confirmed COVID-19 Patient https://ClinicalTrials.gov/show/NCT04366947
NCT04366297 Intravascular Access of COVID-19 Patient Under Personal Protective Equipment https://ClinicalTrials.gov/show/NCT04366297
NCT04366271 Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04366271
NCT04364022 Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland https://ClinicalTrials.gov/show/NCT04364022
NCT04363502 Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection https://ClinicalTrials.gov/show/NCT04363502
NCT04363450 Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP) https://ClinicalTrials.gov/show/NCT04363450
NCT04363437 COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04363437
NCT04363346 Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia https://ClinicalTrials.gov/show/NCT04363346
NCT04363203 VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL) https://ClinicalTrials.gov/show/NCT04363203
NCT04361253 Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy https://ClinicalTrials.gov/show/NCT04361253
NCT04393961 At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study https://ClinicalTrials.gov/show/NCT04393961
NCT04385095 Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04385095
NCT04368988 Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant https://ClinicalTrials.gov/show/NCT04368988
NCT04368923 Management of Covid-19 Patients During Home Isolation https://ClinicalTrials.gov/show/NCT04368923
NCT04368260 Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04368260
NCT04368000 Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization https://ClinicalTrials.gov/show/NCT04368000
NCT04366960 Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04366960
NCT04366791 Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 https://ClinicalTrials.gov/show/NCT04366791
NCT04365972 Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic https://ClinicalTrials.gov/show/NCT04365972
NCT04365608 Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment https://ClinicalTrials.gov/show/NCT04365608
NCT04365309 Protective Effect of Aspirin on COVID-19 Patients https://ClinicalTrials.gov/show/NCT04365309
NCT04365257 Prazosin to Prevent COVID-19 (PREVENT-COVID Trial) https://ClinicalTrials.gov/show/NCT04365257
NCT04365153 Canakinumab to Reduce Deterioration of Cardiac and Respiratory Function Due to COVID-19 https://ClinicalTrials.gov/show/NCT04365153
NCT04365127 Progesterone for the Treatment of COVID-19 in Hospitalized Men https://ClinicalTrials.gov/show/NCT04365127
NCT04363593 Serology COVID-19 From the Cornwall Hospital Union https://ClinicalTrials.gov/show/NCT04363593
NCT04367168 Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease https://ClinicalTrials.gov/show/NCT04367168
NCT04363827 Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04363827
NCT04372589 Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC ) https://ClinicalTrials.gov/show/NCT04372589
NCT04363606 Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability https://ClinicalTrials.gov/show/NCT04363606
NCT04362813 Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia https://ClinicalTrials.gov/show/NCT04362813
NCT04392778 Clinical Use of Stem Cells for the Treatment of Covid-19 https://ClinicalTrials.gov/show/NCT04392778
NCT04372017 Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection https://ClinicalTrials.gov/show/NCT04372017
NCT04369742 Treating COVID-19 With Hydroxychloroquine (TEACH) https://ClinicalTrials.gov/show/NCT04369742
NCT04365699 Cardiovascular Effects of COVID-19 https://ClinicalTrials.gov/show/NCT04365699
NCT04364802 COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients https://ClinicalTrials.gov/show/NCT04364802
NCT04373824 Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study https://ClinicalTrials.gov/show/NCT04373824
NCT04370782 Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting https://ClinicalTrials.gov/show/NCT04370782
NCT04365985 Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 https://ClinicalTrials.gov/show/NCT04365985
NCT04365738 Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04365738
NCT04389710 Convalescent Plasma for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04389710
NCT04379453 Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses https://ClinicalTrials.gov/show/NCT04379453
NCT04374565 Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia https://ClinicalTrials.gov/show/NCT04374565
NCT04372693 Unplanned Shifting to Online Distance Learning: Nursing Students’ Perception and Achievement https://ClinicalTrials.gov/show/NCT04372693
NCT04370262 Multi-site Adaptive Trials Using Hydroxycholoroquine for COVID-19 https://ClinicalTrials.gov/show/NCT04370262
NCT04369456 Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients https://ClinicalTrials.gov/show/NCT04369456
NCT04369365 A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic https://ClinicalTrials.gov/show/NCT04369365
NCT04369066 COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie https://ClinicalTrials.gov/show/NCT04369066
NCT04367831 Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 https://ClinicalTrials.gov/show/NCT04367831
NCT04367545 Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04367545
NCT04367077 MultiStem Administration for COVID-19 Induced ARDS (MACoVIA) https://ClinicalTrials.gov/show/NCT04367077
NCT04366180 Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers https://ClinicalTrials.gov/show/NCT04366180
NCT04368728 Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04368728
NCT04379154 Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04379154
NCT04376476 Host-pathogen Interactions During SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04376476
NCT04371640 Sirolimus in COVID-19 Phase 1 https://ClinicalTrials.gov/show/NCT04371640
NCT04371510 Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients https://ClinicalTrials.gov/show/NCT04371510
NCT04371419 COVID-19 Health Messaging to Underserved Communities https://ClinicalTrials.gov/show/NCT04371419
NCT04371029 Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS https://ClinicalTrials.gov/show/NCT04371029
NCT04406181 Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04406181
NCT04371393 MSCs in COVID-19 ARDS https://ClinicalTrials.gov/show/NCT04371393
NCT04370886 Recruit Blood Donors Via SMS During Epidemic of COVID-19 https://ClinicalTrials.gov/show/NCT04370886
NCT04385810 Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19 https://ClinicalTrials.gov/show/NCT04385810
NCT04384588 COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID) https://ClinicalTrials.gov/show/NCT04384588
NCT04380532 Tableted COVID-19 Therapeutic Vaccine https://ClinicalTrials.gov/show/NCT04380532
NCT04378712 Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04378712
NCT04375202 Colchicine in COVID-19: a Pilot Study https://ClinicalTrials.gov/show/NCT04375202
NCT04371367 Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE ) https://ClinicalTrials.gov/show/NCT04371367
NCT04370938 Provider Burnout During COVID-19 https://ClinicalTrials.gov/show/NCT04370938
NCT04370288 Clinical Application of Methylene Blue for Treatment of Covid-19 Patients https://ClinicalTrials.gov/show/NCT04370288
NCT04369820 C5a Receptor Expression - COVID-19 (C5-COV) https://ClinicalTrials.gov/show/NCT04369820
NCT04372186 A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04372186
NCT04379531 LDCT in COVID-19 Pneumonia: a Prospective Moscow Study https://ClinicalTrials.gov/show/NCT04379531
NCT04374942 Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus? https://ClinicalTrials.gov/show/NCT04374942
NCT04374032 Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04374032
NCT04373161 Home Pulse Oximeter Use in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04373161
NCT04373135 Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19 https://ClinicalTrials.gov/show/NCT04373135
NCT04372680 WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound https://ClinicalTrials.gov/show/NCT04372680
NCT04408066 COVID-19: A POC Test Under Research & Evaluation https://ClinicalTrials.gov/show/NCT04408066
NCT04378738 Social Media and Covid19 Pandemic https://ClinicalTrials.gov/show/NCT04378738
NCT04377789 Effect of Quercetin on Prophylaxis and Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04377789
NCT04375124 Treatment of Angiotensin Peptide (1-7) for COVID-19 https://ClinicalTrials.gov/show/NCT04375124
NCT04374019 Novel Agents for Treatment of High-risk COVID-19 Positive Patients https://ClinicalTrials.gov/show/NCT04374019
NCT04373707 Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 https://ClinicalTrials.gov/show/NCT04373707
NCT04374461 A Study of N-acetylcysteine in Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04374461
NCT04374786 Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04374786
NCT04374591 Home-based Treatment of Computed Tomography and Clinically Suspected Novel COVID-19 With Adjuvant Inhalable Sodium Bicarbonate: A Preliminary Case Series https://ClinicalTrials.gov/show/NCT04374591
NCT04374539 Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT04374539
NCT04374526 Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression. https://ClinicalTrials.gov/show/NCT04374526
NCT04392531 Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19 https://ClinicalTrials.gov/show/NCT04392531
NCT04376593 PET/CT Imaging in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04376593
NCT04375098 Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection https://ClinicalTrials.gov/show/NCT04375098
NCT04376814 Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19 https://ClinicalTrials.gov/show/NCT04376814
NCT04391712 Cold Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease https://ClinicalTrials.gov/show/NCT04391712
NCT04385043 Hyperimmune Plasma in Patients With COVID-19 Severe Infection https://ClinicalTrials.gov/show/NCT04385043
NCT04379336 BCG Vaccination for Healthcare Workers in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04379336
NCT04377477 COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19) https://ClinicalTrials.gov/show/NCT04377477
NCT04378803 Mindfulness Training for Seniors https://ClinicalTrials.gov/show/NCT04378803
NCT04388527 COVID-19 Convalescent Plasma for Mechanically Ventilated Population https://ClinicalTrials.gov/show/NCT04388527
NCT04377659 Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04377659
NCT04380818 Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19 https://ClinicalTrials.gov/show/NCT04380818
NCT04377672 Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04377672
NCT04377620 Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT) https://ClinicalTrials.gov/show/NCT04377620
NCT04376684 Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease https://ClinicalTrials.gov/show/NCT04376684
NCT04375397 Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury https://ClinicalTrials.gov/show/NCT04375397
NCT04392713 Efficacy of Ivermectin in COVID-19 https://ClinicalTrials.gov/show/NCT04392713
NCT04389372 Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse https://ClinicalTrials.gov/show/NCT04389372
NCT04383613 Prone Positioning for Patients on General Medical Wards With COVID19 https://ClinicalTrials.gov/show/NCT04383613
NCT04381884 Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04381884
NCT04379661 SUNLIGHT Study: Online Support Groups for MS to Address COVID-19 https://ClinicalTrials.gov/show/NCT04379661
NCT04379492 A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19 https://ClinicalTrials.gov/show/NCT04379492
NCT04379076 InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort https://ClinicalTrials.gov/show/NCT04379076
NCT04378920 A Study of Trans Crocetin in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Disease (LEAF-4L7520/4L6715) https://ClinicalTrials.gov/show/NCT04378920
NCT04382768 Inhaled Ibuprofen to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04382768
NCT04382092 Co-infection Management in COVID-19 Critically Ill https://ClinicalTrials.gov/show/NCT04382092
NCT04381858 Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04381858
NCT04380701 A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults https://ClinicalTrials.gov/show/NCT04380701
NCT04380519 Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04380519
NCT04380376 Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia https://ClinicalTrials.gov/show/NCT04380376
NCT04385901 Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth https://ClinicalTrials.gov/show/NCT04385901
NCT04390477 Study to Evaluate the Effect of a Probiotic in COVID-19 https://ClinicalTrials.gov/show/NCT04390477
NCT04390139 Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19 https://ClinicalTrials.gov/show/NCT04390139
NCT04390022 Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial https://ClinicalTrials.gov/show/NCT04390022
NCT04384497 Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study https://ClinicalTrials.gov/show/NCT04384497
NCT04381377 Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19 https://ClinicalTrials.gov/show/NCT04381377
NCT04381000 Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic. https://ClinicalTrials.gov/show/NCT04381000
NCT04380961 A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19 https://ClinicalTrials.gov/show/NCT04380961
NCT04380909 ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation https://ClinicalTrials.gov/show/NCT04380909
NCT04382040 A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19 https://ClinicalTrials.gov/show/NCT04382040
NCT04381936 Randomised Evaluation of COVID-19 Therapy https://ClinicalTrials.gov/show/NCT04381936
NCT04382066 Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04382066
NCT04390464 mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R) https://ClinicalTrials.gov/show/NCT04390464
NCT04389294 HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists https://ClinicalTrials.gov/show/NCT04389294
NCT04386694 Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04386694
NCT04382729 Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia https://ClinicalTrials.gov/show/NCT04382729
NCT04381988 A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy https://ClinicalTrials.gov/show/NCT04381988
NCT04382547 Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells https://ClinicalTrials.gov/show/NCT04382547
NCT04384965 Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04384965
NCT04405986 Exploring Brain Damages After COVID-19 Infection https://ClinicalTrials.gov/show/NCT04405986
NCT04394416 Trial of Imatinib for Hospitalized Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04394416
NCT04382053 Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04382053
NCT04389333 Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04389333
NCT04385199 Convalescent Plasma for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04385199
NCT04391140 Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS https://ClinicalTrials.gov/show/NCT04391140
NCT04385836 Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) https://ClinicalTrials.gov/show/NCT04385836
NCT04385017 Role of Inflammasomes in COVID-19 Disease https://ClinicalTrials.gov/show/NCT04385017
NCT04388514 Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure https://ClinicalTrials.gov/show/NCT04388514
NCT04386850 Oral 25-hydroxyvitamin D3 and COVID-19 https://ClinicalTrials.gov/show/NCT04386850
NCT04386616 A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04386616
NCT04384900 Accelerated Prone Position Ventilation of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04384900
NCT04386291 Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19 https://ClinicalTrials.gov/show/NCT04386291
NCT04391127 Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04391127
NCT04390191 Early CPAP in COVID-19 Confirmed or Suspected Patients https://ClinicalTrials.gov/show/NCT04390191
NCT04389944 Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19 https://ClinicalTrials.gov/show/NCT04389944
NCT04389385 COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo) https://ClinicalTrials.gov/show/NCT04389385
NCT04387292 Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic https://ClinicalTrials.gov/show/NCT04387292
NCT04412330 Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19 https://ClinicalTrials.gov/show/NCT04412330
NCT04390412 Low Dose Radiotherapy in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04390412
NCT04388683 Inhaled Nitric Oxide for Preventing Progression in COVID-19 https://ClinicalTrials.gov/show/NCT04388683
NCT04405076 Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older https://ClinicalTrials.gov/show/NCT04405076
NCT04388826 COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 https://ClinicalTrials.gov/show/NCT04388826
NCT04392414 Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease https://ClinicalTrials.gov/show/NCT04392414
NCT04389840 Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure https://ClinicalTrials.gov/show/NCT04389840
NCT04390503 Convalescent Plasma for COVID-19 Close Contacts https://ClinicalTrials.gov/show/NCT04390503
NCT04390516 Respiratory Decompensation and Model for the Triage of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04390516
NCT04395144 COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss https://ClinicalTrials.gov/show/NCT04395144
NCT04394182 Ultra Low Doses of Therapy With Radiation Applicated to COVID-19 https://ClinicalTrials.gov/show/NCT04394182
NCT04392323 Incidence of COVID-19 Test Conversion in Post-surgical Patients https://ClinicalTrials.gov/show/NCT04392323
NCT04392232 A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection https://ClinicalTrials.gov/show/NCT04392232
NCT04392141 Colchicine Plus Phenolic Monoterpenes to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04392141
NCT04391179 Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19 https://ClinicalTrials.gov/show/NCT04391179
NCT04395105 Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT04395105
NCT04393727 Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04393727
NCT04407208 Convalescent Plasma Therapy in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04407208
NCT04398004 Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early https://ClinicalTrials.gov/show/NCT04398004
NCT04394442 Hydroxychloroquine in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04394442
NCT04403269 NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE https://ClinicalTrials.gov/show/NCT04403269
NCT04402918 Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy https://ClinicalTrials.gov/show/NCT04402918
NCT04393792 SINUS WASH Pilot Study in Adults Testing Positive for COVID-19 https://ClinicalTrials.gov/show/NCT04393792
NCT04393038 ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04393038
NCT04405999 Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease https://ClinicalTrials.gov/show/NCT04405999
NCT04395807 Helmet CPAP Versus HFNC in COVID-19 https://ClinicalTrials.gov/show/NCT04395807
NCT04402203 Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh https://ClinicalTrials.gov/show/NCT04402203
NCT04399746 Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19 https://ClinicalTrials.gov/show/NCT04399746
NCT04399005 The Efficacy Comparing Daily and After-each-case Room Disinfection. https://ClinicalTrials.gov/show/NCT04399005
NCT04407286 Vitamin D Testing and Treatment for COVID 19 https://ClinicalTrials.gov/show/NCT04407286
NCT04397757 COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2. https://ClinicalTrials.gov/show/NCT04397757
NCT04397510 Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury https://ClinicalTrials.gov/show/NCT04397510
NCT04416360 Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04416360
NCT04397562 A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04397562
NCT04403477 Convalescent Plasma Therapy in Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04403477
NCT04401293 Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients https://ClinicalTrials.gov/show/NCT04401293
NCT04398277 A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04398277
NCT04397523 Efficacy and Safety of COVID-19 Convalescent Plasma https://ClinicalTrials.gov/show/NCT04397523
NCT04397666 RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04397666
NCT04402970 Dornase Alfa for ARDS in Patients With SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04402970
NCT04401202 Nigella Sativa in COVID-19 https://ClinicalTrials.gov/show/NCT04401202
NCT04400305 “Increasing Physical Activity in Canadian Adults Who Have Been Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention” https://ClinicalTrials.gov/show/NCT04400305
NCT04399980 Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation https://ClinicalTrials.gov/show/NCT04399980
NCT04399681 The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19 https://ClinicalTrials.gov/show/NCT04399681
NCT04399109 Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER) https://ClinicalTrials.gov/show/NCT04399109
NCT04410549 Pulmonary Optical Coherence Tomography in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04410549
NCT04413006 Self-compassion for Chronic Pain Virtual Group Treatment Program https://ClinicalTrials.gov/show/NCT04413006
NCT04412538 Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 https://ClinicalTrials.gov/show/NCT04412538
NCT04402983 The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients https://ClinicalTrials.gov/show/NCT04402983
NCT04402840 Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS) https://ClinicalTrials.gov/show/NCT04402840
NCT04411602 Feasibility Study of Anti-SARS-CoV-2 Plasma Transfusions in COVID-19 Patients With SRD https://ClinicalTrials.gov/show/NCT04411602
NCT04407390 Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly https://ClinicalTrials.gov/show/NCT04407390
NCT04402879 CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals https://ClinicalTrials.gov/show/NCT04402879
NCT04408183 GLS-1200Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel https://ClinicalTrials.gov/show/NCT04408183
NCT04401579 Adaptive COVID-19 Treatment Trial 2 (ACTT-II) https://ClinicalTrials.gov/show/NCT04401579
NCT04406493 Monitoring COVID-19 Patients’ Lung Fluid Using Impedance Technique https://ClinicalTrials.gov/show/NCT04406493
NCT04411433 Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04411433
NCT04406246 Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide https://ClinicalTrials.gov/show/NCT04406246
NCT04403685 Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers https://ClinicalTrials.gov/show/NCT04403685
NCT04408456 Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04408456
NCT04412356 Timing of Tracheotomy in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04412356
NCT04407182 Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 https://ClinicalTrials.gov/show/NCT04407182
NCT04408209 Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04408209
NCT04417335 Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination https://ClinicalTrials.gov/show/NCT04417335
NCT04405310 Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial https://ClinicalTrials.gov/show/NCT04405310
NCT04410562 Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy https://ClinicalTrials.gov/show/NCT04410562
NCT04405544 Determination of Acute Encephalopathy Predictors in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04405544
NCT04409496 Chat-based Support for Preveting Smoking Relapse https://ClinicalTrials.gov/show/NCT04409496
NCT04410692 Can the Prediction Market Improve Predictions of COVID-19? https://ClinicalTrials.gov/show/NCT04410692
NCT04416308 COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB) https://ClinicalTrials.gov/show/NCT04416308
NCT04408131 Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study https://ClinicalTrials.gov/show/NCT04408131
NCT04409743 Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04409743
NCT04409522 Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients https://ClinicalTrials.gov/show/NCT04409522
NCT04409327 Phase 3 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes https://ClinicalTrials.gov/show/NCT04409327
NCT04412486 COVID-19 Convalescent Plasma (CCP) Transfusion https://ClinicalTrials.gov/show/NCT04412486
NCT04410458 Recruit Blood Donors Via SMS During Epidemic of COVID-19 (Repeat Trial) https://ClinicalTrials.gov/show/NCT04410458
NCT04412343 The Seniors COvid-19 Pandemic and Exercise Study https://ClinicalTrials.gov/show/NCT04412343
NCT04411667 Study of Standard of Care Plus Intravenous Immunoglobulin (IVIG) Compared to Standard of Care Alone in the Treatment of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04411667
NCT04415073 A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19 https://ClinicalTrials.gov/show/NCT04415073
NCT04412018 An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19 https://ClinicalTrials.gov/show/NCT04412018
NCT04411628 A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19 https://ClinicalTrials.gov/show/NCT04411628
NCT04412239 To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04412239
NCT04416139 Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19 https://ClinicalTrials.gov/show/NCT04416139
NCT04414371 Tools for Wellbeing COVID-19 National Study of Undergraduate Students https://ClinicalTrials.gov/show/NCT04414371
NCT04412772 A RCT - Safety & Efficacy of Tocilizumab - Tx of Severe COVID-19: ARCHITECTS https://ClinicalTrials.gov/show/NCT04412772
NCT04414267 Bacillus Calmette-guérin Vaccination to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04414267
NCT04414124 A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19 https://ClinicalTrials.gov/show/NCT04414124
NCT04412668 Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19 https://ClinicalTrials.gov/show/NCT04412668

Observational Studies

nct_id brief_title link
NCT04245631 Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV https://ClinicalTrials.gov/show/NCT04245631
NCT04256395 Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19 https://ClinicalTrials.gov/show/NCT04256395
NCT04260308 A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia https://ClinicalTrials.gov/show/NCT04260308
NCT04255940 2019-nCoV Outbreak and Cardiovascular Diseases https://ClinicalTrials.gov/show/NCT04255940
NCT04259892 Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19. https://ClinicalTrials.gov/show/NCT04259892
NCT04283396 Study for Novel Coronavirus Pneumonia (NCP) https://ClinicalTrials.gov/show/NCT04283396
NCT04279782 Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection https://ClinicalTrials.gov/show/NCT04279782
NCT04274322 Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool https://ClinicalTrials.gov/show/NCT04274322
NCT04275947 The COVID-19 Mobile Health Study (CMHS) https://ClinicalTrials.gov/show/NCT04275947
NCT04279899 The Investigation of the Neonates With or With Risk of COVID-19 https://ClinicalTrials.gov/show/NCT04279899
NCT04279795 Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations https://ClinicalTrials.gov/show/NCT04279795
NCT04284046 CT Scores Predict Mortality in 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04284046
NCT04292327 Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus https://ClinicalTrials.gov/show/NCT04292327
NCT04285801 Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study https://ClinicalTrials.gov/show/NCT04285801
NCT04292340 Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04292340
NCT04290780 COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus https://ClinicalTrials.gov/show/NCT04290780
NCT04292964 Prognostic Factors of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04292964
NCT04306497 TCM Differentiation and Treatment Protocol of COVID-19 https://ClinicalTrials.gov/show/NCT04306497
NCT04312464 Myocardial Damage in COVID-19 https://ClinicalTrials.gov/show/NCT04312464
NCT04302688 Accurate Classification System for Patients With COVID-19 Pneumonitis https://ClinicalTrials.gov/show/NCT04302688
NCT04306705 Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19 https://ClinicalTrials.gov/show/NCT04306705
NCT04307459 Acute Respiratory Failure and COVID-19 in Real Life https://ClinicalTrials.gov/show/NCT04307459
NCT04316884 Mechanisms for Organ Dysfunction in Covid-19 https://ClinicalTrials.gov/show/NCT04316884
NCT04312100 Sequential Oxygen Therapy Strategy for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04312100
NCT04319315 Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak https://ClinicalTrials.gov/show/NCT04319315
NCT04316299 Acute Kidney Injury in Patients Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04316299
NCT04314817 Adverse Events Related to Treatments Used Against Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04314817
NCT04313946 Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays https://ClinicalTrials.gov/show/NCT04313946
NCT04347369 A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease https://ClinicalTrials.gov/show/NCT04347369
NCT04321265 Outcomes and Prognostic Factors in COVID-19 https://ClinicalTrials.gov/show/NCT04321265
NCT04318366 COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor https://ClinicalTrials.gov/show/NCT04318366
NCT04316949 Predictors of Respiratory Failure in SARS-Cov-2 Infection https://ClinicalTrials.gov/show/NCT04316949
NCT04320017 Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19 https://ClinicalTrials.gov/show/NCT04320017
NCT04318301 Hypertension in Patients Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04318301
NCT04322513 Biomarkers for Identification of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04322513
NCT04322487 Simple, Safe, Same: Lung Ultrasound for COVID-19 https://ClinicalTrials.gov/show/NCT04322487
NCT04321369 Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals https://ClinicalTrials.gov/show/NCT04321369
NCT04320732 Risk Factors for Community- and Workplace Transmission of COVID-19 https://ClinicalTrials.gov/show/NCT04320732
NCT04320511 Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2 https://ClinicalTrials.gov/show/NCT04320511
NCT04325919 Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong https://ClinicalTrials.gov/show/NCT04325919
NCT04323787 Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry https://ClinicalTrials.gov/show/NCT04323787
NCT04322279 Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID19. https://ClinicalTrials.gov/show/NCT04322279
NCT04322188 An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications https://ClinicalTrials.gov/show/NCT04322188
NCT04327180 PREdiction of DIagnosed Covid-19 infecTion in IUC Patients https://ClinicalTrials.gov/show/NCT04327180
NCT04324736 “COVID-19 and Diabetes Outcomes” https://ClinicalTrials.gov/show/NCT04324736
NCT04324684 Prognostic Factors Keeping Track for COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04324684
NCT04324047 Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04324047
NCT04323644 Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg) https://ClinicalTrials.gov/show/NCT04323644
NCT04332913 Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia https://ClinicalTrials.gov/show/NCT04332913
NCT04327804 A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research https://ClinicalTrials.gov/show/NCT04327804
NCT04326725 Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia https://ClinicalTrials.gov/show/NCT04326725
NCT04326387 Evaluation of Novel Diagnostic Tests for COVID-19 https://ClinicalTrials.gov/show/NCT04326387
NCT04325646 Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France https://ClinicalTrials.gov/show/NCT04325646
NCT04331106 Survey of the Anxiety Associated With the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04331106
NCT04328454 Clinical Characteristics and Prognostic Factors of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04328454
NCT04327531 Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study https://ClinicalTrials.gov/show/NCT04327531
NCT04329546 Understanding COVID-19 https://ClinicalTrials.gov/show/NCT04329546
NCT04336384 Impact of Covid-19 in Congenital Heart Disease https://ClinicalTrials.gov/show/NCT04336384
NCT04332016 COVID-19 Biological Samples Collection https://ClinicalTrials.gov/show/NCT04332016
NCT04330261 Clinical Characteristics and Outcomes of Pediatric COVID-19 https://ClinicalTrials.gov/show/NCT04330261
NCT04340219 Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04340219
NCT04335188 COVID-19 Registry Rhineland-Palatinate (Germany) https://ClinicalTrials.gov/show/NCT04335188
NCT04331886 An Observational Study of Patients With Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04331886
NCT04331509 COVID-19 Symptom Tracker https://ClinicalTrials.gov/show/NCT04331509
NCT04333862 Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy https://ClinicalTrials.gov/show/NCT04333862
NCT04333849 Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19 https://ClinicalTrials.gov/show/NCT04333849
NCT04336215 Rutgers COVID-19 Cohort Study https://ClinicalTrials.gov/show/NCT04336215
NCT04335630 Cardiovascular Manifestations of COVID-19 https://ClinicalTrials.gov/show/NCT04335630
NCT04334252 Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia https://ClinicalTrials.gov/show/NCT04334252
NCT04340921 The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury https://ClinicalTrials.gov/show/NCT04340921
NCT04337190 Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2) https://ClinicalTrials.gov/show/NCT04337190
NCT04337151 Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment https://ClinicalTrials.gov/show/NCT04337151
NCT04337047 Distress in Crisis Situations During COVID-19 https://ClinicalTrials.gov/show/NCT04337047
NCT04336761 Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France https://ClinicalTrials.gov/show/NCT04336761
NCT04336657 Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease? https://ClinicalTrials.gov/show/NCT04336657
NCT04335162 Cardiovascular Complications and COVID-19 (CovCardioVasc) https://ClinicalTrials.gov/show/NCT04335162
NCT04335747 COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases https://ClinicalTrials.gov/show/NCT04335747
NCT04334954 SARS-COV2 Pandemic Serosurvey and Blood Sampling https://ClinicalTrials.gov/show/NCT04334954
NCT04342702 A Study on the Prospective Cohort Library of COVID-19 in Southeran https://ClinicalTrials.gov/show/NCT04342702
NCT04338672 The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients https://ClinicalTrials.gov/show/NCT04338672
NCT04337424 Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04337424
NCT04366765 COVID-19 Survival - The COVIVA Study https://ClinicalTrials.gov/show/NCT04366765
NCT04346602 A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019 https://ClinicalTrials.gov/show/NCT04346602
NCT04339998 Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS) https://ClinicalTrials.gov/show/NCT04339998
NCT04339387 COVID-19 Risk Stratification https://ClinicalTrials.gov/show/NCT04339387
NCT04337762 Beat COVID-19 - Observational Trial https://ClinicalTrials.gov/show/NCT04337762
NCT04337502 Clinical and Radiomic Model of COVID-19 https://ClinicalTrials.gov/show/NCT04337502
NCT04343742 Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19 https://ClinicalTrials.gov/show/NCT04343742
NCT04342637 COVID-19 Endoscopy Survey https://ClinicalTrials.gov/show/NCT04342637
NCT04339634 Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy https://ClinicalTrials.gov/show/NCT04339634
NCT04339608 Max COVID19- Study https://ClinicalTrials.gov/show/NCT04339608
NCT04338945 Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy https://ClinicalTrials.gov/show/NCT04338945
NCT04338932 COVID-19 and Deep Venous Thrombosis https://ClinicalTrials.gov/show/NCT04338932
NCT04347408 Seroprevalence of SARS-Cov-2 Antibodies in Children https://ClinicalTrials.gov/show/NCT04347408
NCT04352634 The Covid-19 HEalth caRe wOrkErS (HEROES) Study https://ClinicalTrials.gov/show/NCT04352634
NCT04347928 Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19 https://ClinicalTrials.gov/show/NCT04347928
NCT04347460 Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH https://ClinicalTrials.gov/show/NCT04347460
NCT04343404 PLACE OF VENOVENOUS ECMO IN THE MANAGEMENT OF SEVERE REFRACTORY ARDS ASSOCIATED WITH SARS-COV-2 https://ClinicalTrials.gov/show/NCT04343404
NCT04343339 Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment https://ClinicalTrials.gov/show/NCT04343339
NCT04342884 COVID-19 Community Research Partnership https://ClinicalTrials.gov/show/NCT04342884
NCT04342195 Acquiring Convalescent Specimens for COVID-19 Antibodies https://ClinicalTrials.gov/show/NCT04342195
NCT04342104 NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure https://ClinicalTrials.gov/show/NCT04342104
NCT04341714 Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04341714
NCT04339686 Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening. https://ClinicalTrials.gov/show/NCT04339686
NCT04339790 Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers https://ClinicalTrials.gov/show/NCT04339790
NCT04358952 Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients https://ClinicalTrials.gov/show/NCT04358952
NCT04357847 Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04357847
NCT04352556 COVID19-hematological Malignancies: the Italian Hematology Alliance https://ClinicalTrials.gov/show/NCT04352556
NCT04350710 Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS https://ClinicalTrials.gov/show/NCT04350710
NCT04347850 A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04347850
NCT04346342 PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID) https://ClinicalTrials.gov/show/NCT04346342
NCT04344327 Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF https://ClinicalTrials.gov/show/NCT04344327
NCT04344197 Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey https://ClinicalTrials.gov/show/NCT04344197
NCT04344119 Assessment of Chilbains Occuring During Covid-19 Infection https://ClinicalTrials.gov/show/NCT04344119
NCT04343898 Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04343898
NCT04343781 National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19 https://ClinicalTrials.gov/show/NCT04343781
NCT04344145 Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population https://ClinicalTrials.gov/show/NCT04344145
NCT04347824 Predict Adverse Events by Covid-19 Nephritis https://ClinicalTrials.gov/show/NCT04347824
NCT04381312 Direct and Indirect Impact of COVID-19 In Older Populations https://ClinicalTrials.gov/show/NCT04381312
NCT04352517 Influence Physical Activity Psychological Responses COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04352517
NCT04347070 Implementation of Physiotherapy on COVID-19 Patients in ICU https://ClinicalTrials.gov/show/NCT04347070
NCT04346212 Oropharyngeal Dysphagia in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04346212
NCT04345640 The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver. https://ClinicalTrials.gov/show/NCT04345640
NCT04345315 Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent. https://ClinicalTrials.gov/show/NCT04345315
NCT04345159 Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease https://ClinicalTrials.gov/show/NCT04345159
NCT04344171 CovidDB: The Covid-19 Inpatient Database https://ClinicalTrials.gov/show/NCT04344171
NCT04353934 The Ariel University Survey on Dietary Changes and Anxiety During the Coronavirus Pandemic https://ClinicalTrials.gov/show/NCT04353934
NCT04347694 Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic. https://ClinicalTrials.gov/show/NCT04347694
NCT04373889 COVID-19 Among Healthcare Workers in Belgian Hospitals https://ClinicalTrials.gov/show/NCT04373889
NCT04356560 COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department https://ClinicalTrials.gov/show/NCT04356560
NCT04354584 Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04354584
NCT04352582 COVID-19 and Vaccination Attitudes https://ClinicalTrials.gov/show/NCT04352582
NCT04349163 Resilience Evaluation of Caregivers During the SARS-CoV2 Epidemic Period : Prospective Cohort. https://ClinicalTrials.gov/show/NCT04349163
NCT04349202 Beaumont Health Large-scale Automated Serologic Testing for COVID-19 https://ClinicalTrials.gov/show/NCT04349202
NCT04346264 CoVid-19 - Infection and Antibody Formation in the Viennese Population https://ClinicalTrials.gov/show/NCT04346264
NCT04346056 Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19 https://ClinicalTrials.gov/show/NCT04346056
NCT04348214 Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals https://ClinicalTrials.gov/show/NCT04348214
NCT04344977 Collection of Anti-SARS-CoV-2 Immune Plasma https://ClinicalTrials.gov/show/NCT04344977
NCT04352699 Outcomes of Urological Surgery During Periods of Social COVID-19 Containemnt: is it Reasonable to Limit Access to Surgical Care for All? https://ClinicalTrials.gov/show/NCT04352699
NCT04351399 Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04351399
NCT04349540 Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19 https://ClinicalTrials.gov/show/NCT04349540
NCT04347876 Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis? https://ClinicalTrials.gov/show/NCT04347876
NCT04352491 An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease https://ClinicalTrials.gov/show/NCT04352491
NCT04351568 Professional and Ethical Challenges of Social Media Usage in Providing Healthcare Services During the Period of 19 Covid Pandemics; https://ClinicalTrials.gov/show/NCT04351568
NCT04386109 Neonatal Complications of Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04386109
NCT04353609 Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases https://ClinicalTrials.gov/show/NCT04353609
NCT04353401 WGS ANALYSIS OF SARS-COV-2 POSITIVE PATIENTS https://ClinicalTrials.gov/show/NCT04353401
NCT04353011 Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04353011
NCT04351633 Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04351633
NCT04351503 A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19 https://ClinicalTrials.gov/show/NCT04351503
NCT04351139 Impact of the COVID-19 Pandemic in Gynecological Oncology https://ClinicalTrials.gov/show/NCT04351139
NCT04348240 Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions https://ClinicalTrials.gov/show/NCT04348240
NCT04376905 Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04376905
NCT04373109 Stroke Rehabilitation Outcome During COVID-19 Lockdown https://ClinicalTrials.gov/show/NCT04373109
NCT04367129 Electrocardiogram Analysis in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04367129
NCT04366154 Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers https://ClinicalTrials.gov/show/NCT04366154
NCT04360538 Long Term Outcomes of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04360538
NCT04359667 Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab https://ClinicalTrials.gov/show/NCT04359667
NCT04357769 COVID-19 Pandemic Burden in Severe Mental Disease Patients https://ClinicalTrials.gov/show/NCT04357769
NCT04357418 Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives https://ClinicalTrials.gov/show/NCT04357418
NCT04356443 Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04356443
NCT04354792 Asymptomatic COVID-19 Infection Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04354792
NCT04353141 International Lung UltraSound Analysis (ILUSA) Study https://ClinicalTrials.gov/show/NCT04353141
NCT04352842 Echocardiographic Manifestation in Patient With COVID-19 (EARLY-MYO COVID-19) https://ClinicalTrials.gov/show/NCT04352842
NCT04351659 Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04351659
NCT04355442 Evolution of Facial Trauma During COVID Containment Measures https://ClinicalTrials.gov/show/NCT04355442
NCT04367402 COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION) https://ClinicalTrials.gov/show/NCT04367402
NCT04367363 Social Media and COVID-19 https://ClinicalTrials.gov/show/NCT04367363
NCT04366921 European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO https://ClinicalTrials.gov/show/NCT04366921
NCT04361786 Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection https://ClinicalTrials.gov/show/NCT04361786
NCT04355715 Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia https://ClinicalTrials.gov/show/NCT04355715
NCT04355624 Kidney Involvement in COVID-19 Disease (COVKID) https://ClinicalTrials.gov/show/NCT04355624
NCT04355611 Epidemiological Characteristics of COVID-19 in Patients With MS or NMO https://ClinicalTrials.gov/show/NCT04355611
NCT04355481 Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit https://ClinicalTrials.gov/show/NCT04355481
NCT04354857 Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection https://ClinicalTrials.gov/show/NCT04354857
NCT04354779 Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel. https://ClinicalTrials.gov/show/NCT04354779
NCT04354766 COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2 https://ClinicalTrials.gov/show/NCT04354766
NCT04354753 AiM COVID for Covid 19 Tracking and Prediction https://ClinicalTrials.gov/show/NCT04354753
NCT04357041 COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being https://ClinicalTrials.gov/show/NCT04357041
NCT04355702 Covid-19 in Lupus Patients https://ClinicalTrials.gov/show/NCT04355702
NCT04358380 Liver Injury in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04358380
NCT04365166 Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19) https://ClinicalTrials.gov/show/NCT04365166
NCT04363333 Obstructive Sleep Apnea & Covid-19 Outcomes https://ClinicalTrials.gov/show/NCT04363333
NCT04359914 Neurocognitive Impairment in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04359914
NCT04356885 COVID-19 and Psychotic Symptoms in France https://ClinicalTrials.gov/show/NCT04356885
NCT04355871 Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain https://ClinicalTrials.gov/show/NCT04355871
NCT04385069 COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study https://ClinicalTrials.gov/show/NCT04385069
NCT04384029 The Geneva Covid-19 CVD Study https://ClinicalTrials.gov/show/NCT04384029
NCT04376853 CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch https://ClinicalTrials.gov/show/NCT04376853
NCT04374123 COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit https://ClinicalTrials.gov/show/NCT04374123
NCT04362345 Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04362345
NCT04361877 Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial) https://ClinicalTrials.gov/show/NCT04361877
NCT04360954 Evaluation of Antibody Tests for COVID-19 https://ClinicalTrials.gov/show/NCT04360954
NCT04359849 Sequencing and Tracking of Phylogeny in COVID-19 Study https://ClinicalTrials.gov/show/NCT04359849
NCT04359836 A Study to Explore the Role of Gut Flora in COVID-19 Infection https://ClinicalTrials.gov/show/NCT04359836
NCT04358536 Classification of COVID-19 Infection in Posteroanterior Chest X-rays https://ClinicalTrials.gov/show/NCT04358536
NCT04358510 COVID-19 Mortality Prediction Model https://ClinicalTrials.gov/show/NCT04358510
NCT04358029 Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04358029
NCT04357938 Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections https://ClinicalTrials.gov/show/NCT04357938
NCT04357574 Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19 https://ClinicalTrials.gov/show/NCT04357574
NCT04359407 Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients https://ClinicalTrials.gov/show/NCT04359407
NCT04403009 The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04403009
NCT04397835 Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population https://ClinicalTrials.gov/show/NCT04397835
NCT04375748 Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases https://ClinicalTrials.gov/show/NCT04375748
NCT04366024 A Novel Nomogram to Predict Severity of COVID-19 https://ClinicalTrials.gov/show/NCT04366024
NCT04365959 The Prone Position in Covid-19 Affected Patients https://ClinicalTrials.gov/show/NCT04365959
NCT04363008 COVID 19 Biomarkers https://ClinicalTrials.gov/show/NCT04363008
NCT04360850 Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04360850
NCT04359121 COVID-19 and the Developement of Phobic Fears of Disease https://ClinicalTrials.gov/show/NCT04359121
NCT04358640 Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey https://ClinicalTrials.gov/show/NCT04358640
NCT04357431 COVID-19 Among Egyptian Health Care Providers https://ClinicalTrials.gov/show/NCT04357431
NCT04356365 The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI’s) https://ClinicalTrials.gov/show/NCT04356365
NCT04359693 Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections https://ClinicalTrials.gov/show/NCT04359693
NCT04371848 Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity: a NutriQuébec Sub-study https://ClinicalTrials.gov/show/NCT04371848
NCT04371250 Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures. https://ClinicalTrials.gov/show/NCT04371250
NCT04369807 Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04369807
NCT04366934 Study of the Pathogenesis of Olfactory Disorders in COVID-19 https://ClinicalTrials.gov/show/NCT04366934
NCT04362995 St. Jude Tracking of Viral and Host Factors Associated With COVID-19 https://ClinicalTrials.gov/show/NCT04362995
NCT04362943 Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults https://ClinicalTrials.gov/show/NCT04362943
NCT04361565 Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04361565
NCT04361123 Atrium COVID-19 Syndromic and Serologic Surveillance https://ClinicalTrials.gov/show/NCT04361123
NCT04361019 Physical Activity in University Students Around COVID-19 Confinement https://ClinicalTrials.gov/show/NCT04361019
NCT04360863 The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong https://ClinicalTrials.gov/show/NCT04360863
NCT04360733 Precision Immunology to Determine the Immune Response in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04360733
NCT04360707 Solid Organ Transplant Recipients With SARS-CoV-2 French Registry https://ClinicalTrials.gov/show/NCT04360707
NCT04360278 Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04360278
NCT04393233 Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation https://ClinicalTrials.gov/show/NCT04393233
NCT04396600 The Professional Peer Resilience Initiative https://ClinicalTrials.gov/show/NCT04396600
NCT04381286 Transpulmonary Driving Pressure in ARDS COVID19 Patients https://ClinicalTrials.gov/show/NCT04381286
NCT04366778 Thrombosis and Covid-19 https://ClinicalTrials.gov/show/NCT04366778
NCT04363788 Needle Stick Injuries in Emergency Medical Service Practice https://ClinicalTrials.gov/show/NCT04363788
NCT04363268 ACCESS A Master Digital Surveillance Protocol for COVID-19 https://ClinicalTrials.gov/show/NCT04363268
NCT04363099 Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster. https://ClinicalTrials.gov/show/NCT04363099
NCT04362150 Long-term Impact of Infection With Novel Coronavirus (COVID-19) https://ClinicalTrials.gov/show/NCT04362150
NCT04377815 Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste https://ClinicalTrials.gov/show/NCT04377815
NCT04371315 Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children https://ClinicalTrials.gov/show/NCT04371315
NCT04370678 Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures https://ClinicalTrials.gov/show/NCT04370678
NCT04366167 Patient Recovery From Heart Surgery During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04366167
NCT04365595 SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir) https://ClinicalTrials.gov/show/NCT04365595
NCT04365335 Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04365335
NCT04364698 Observational Cohort of COVID-19 Patients at Raymond-Poincare https://ClinicalTrials.gov/show/NCT04364698
NCT04362930 Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences) https://ClinicalTrials.gov/show/NCT04362930
NCT04362865 Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection https://ClinicalTrials.gov/show/NCT04362865
NCT04365764 Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study https://ClinicalTrials.gov/show/NCT04365764
NCT04365725 Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections https://ClinicalTrials.gov/show/NCT04365725
NCT04365634 A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients. https://ClinicalTrials.gov/show/NCT04365634
NCT04365348 The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families https://ClinicalTrials.gov/show/NCT04365348
NCT04365361 The Psychological Impact of the COVID-19 on Students. https://ClinicalTrials.gov/show/NCT04365361
NCT04382534 A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction https://ClinicalTrials.gov/show/NCT04382534
NCT04373811 One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU Setting https://ClinicalTrials.gov/show/NCT04373811
NCT04368637 Acute Cardiovascular Events Triggered by COVID-19-Related Stress https://ClinicalTrials.gov/show/NCT04368637
NCT04367064 To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study) https://ClinicalTrials.gov/show/NCT04367064
NCT04365881 Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology https://ClinicalTrials.gov/show/NCT04365881
NCT04365530 Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City https://ClinicalTrials.gov/show/NCT04365530
NCT04383470 Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04383470
NCT04368351 Bacteriotherapy in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04368351
NCT04368026 SARS-CoV-2 and Surgery https://ClinicalTrials.gov/show/NCT04368026
NCT04367896 COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY https://ClinicalTrials.gov/show/NCT04367896
NCT04367805 COVID-19 Infection in Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04367805
NCT04367792 Cardiac Injury in COVID-19: a Pathology Study https://ClinicalTrials.gov/show/NCT04367792
NCT04367740 ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19 https://ClinicalTrials.gov/show/NCT04367740
NCT04366752 Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy https://ClinicalTrials.gov/show/NCT04366752
NCT04375670 COVID19-FOIE National Observatory https://ClinicalTrials.gov/show/NCT04375670
NCT04370249 Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19 https://ClinicalTrials.gov/show/NCT04370249
NCT04369989 Observational Study of COVID-19 Treatment Efficacy https://ClinicalTrials.gov/show/NCT04369989
NCT04368390 Neuroradiolological Analysis of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04368390
NCT04368338 Lung Ultrasound to Diagnose COVID-19 https://ClinicalTrials.gov/show/NCT04368338
NCT04367883 Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection https://ClinicalTrials.gov/show/NCT04367883
NCT04367337 Health Behavior Change During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04367337
NCT04367870 COVID-19 Detection Test in Oncology https://ClinicalTrials.gov/show/NCT04367870
NCT04385212 Outcomes in Hospitalized Older Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04385212
NCT04374422 COVID-19 Pandemic and Female Sexual Behavior https://ClinicalTrials.gov/show/NCT04374422
NCT04372576 Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04372576
NCT04372472 SQuISH-COVID: A Pilot Study https://ClinicalTrials.gov/show/NCT04372472
NCT04372056 The COVID-ICU Healthcare Professional Study https://ClinicalTrials.gov/show/NCT04372056
NCT04370275 Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia https://ClinicalTrials.gov/show/NCT04370275
NCT04370197 Covid-19 Epidemic on Acute Stroke Management https://ClinicalTrials.gov/show/NCT04370197
NCT04370119 Screening for SARS-CoV-2-Infections and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers https://ClinicalTrials.gov/show/NCT04370119
NCT04369859 Obstetric and Perinatal Outcomes of Women With COVID-19 https://ClinicalTrials.gov/show/NCT04369859
NCT04368884 Observational Study to Assess the Seroconversion Status of Health Care Workers and Suspected or Confirmed Cases of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04368884
NCT04370210 Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry https://ClinicalTrials.gov/show/NCT04370210
NCT04371432 Genetics of COVID-19 Susceptibility and Manifestations https://ClinicalTrials.gov/show/NCT04371432
NCT04380987 Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis https://ClinicalTrials.gov/show/NCT04380987
NCT04379089 Neurologic Manifestations of COVID 19 in Children https://ClinicalTrials.gov/show/NCT04379089
NCT04377581 COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior https://ClinicalTrials.gov/show/NCT04377581
NCT04376580 Use of the Nasal Cannula During COVID-19 https://ClinicalTrials.gov/show/NCT04376580
NCT04375761 COVID-19: Human Epidemiology and Response to SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04375761
NCT04375410 Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic https://ClinicalTrials.gov/show/NCT04375410
NCT04374071 Early Short Course Corticosteroids in COVID-19 https://ClinicalTrials.gov/show/NCT04374071
NCT04373486 Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels https://ClinicalTrials.gov/show/NCT04373486
NCT04373148 Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19 https://ClinicalTrials.gov/show/NCT04373148
NCT04371679 Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04371679
NCT04371562 Predicting Death and ICU Admission in COVID-19 Patients in ED https://ClinicalTrials.gov/show/NCT04371562
NCT04371471 Covid-19 Pandemic Triage Score https://ClinicalTrials.gov/show/NCT04371471
NCT04384471 Covid-19 Pandemic: Patients’ Experience in T1D https://ClinicalTrials.gov/show/NCT04384471
NCT04378777 Immunophenotyping Assessment in a COVID-19 Cohort https://ClinicalTrials.gov/show/NCT04378777
NCT04377035 The Role of Ultrasound in COVID-19 https://ClinicalTrials.gov/show/NCT04377035
NCT04374656 Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04374656
NCT04374058 Less Frequency Hemodialysis and COVID-19 https://ClinicalTrials.gov/show/NCT04374058
NCT04377412 Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04377412
NCT04374617 Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04374617
NCT04374513 Community Pharmacists Behaviour During Covid-19 https://ClinicalTrials.gov/show/NCT04374513
NCT04374097 Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04374097
NCT04375176 Monocytes and NK Cells Activity in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04375176
NCT04375137 Correlation Between Oxidative Stress Status and COVID-19 Severity https://ClinicalTrials.gov/show/NCT04375137
NCT04382417 Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden https://ClinicalTrials.gov/show/NCT04382417
NCT04381819 Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19 https://ClinicalTrials.gov/show/NCT04381819
NCT04380896 COVID-19 Staff Testing of Antibody Responses Study (Co-Stars) https://ClinicalTrials.gov/show/NCT04380896
NCT04379245 COVID-19 Infection in Patients Infected With HIV and/or on PrEP https://ClinicalTrials.gov/show/NCT04379245
NCT04379232 Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center https://ClinicalTrials.gov/show/NCT04379232
NCT04377607 Haemoglobin Concentration on COVID-19 https://ClinicalTrials.gov/show/NCT04377607
NCT04377074 Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety https://ClinicalTrials.gov/show/NCT04377074
NCT04376996 Slovenian National COVID-19 Prevalence Study https://ClinicalTrials.gov/show/NCT04376996
NCT04376944 Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation https://ClinicalTrials.gov/show/NCT04376944
NCT04376879 Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19) https://ClinicalTrials.gov/show/NCT04376879
NCT04376775 Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation https://ClinicalTrials.gov/show/NCT04376775
NCT04375709 Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19); https://ClinicalTrials.gov/show/NCT04375709
NCT04375501 A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04375501
NCT04379310 Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019) https://ClinicalTrials.gov/show/NCT04379310
NCT04382469 Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT https://ClinicalTrials.gov/show/NCT04382469
NCT04382235 Non-invasive Ventilatory Support of Patients Affected by COVID-19 https://ClinicalTrials.gov/show/NCT04382235
NCT04380870 Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19 https://ClinicalTrials.gov/show/NCT04380870
NCT04379063 COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress https://ClinicalTrials.gov/show/NCT04379063
NCT04378686 Serological Testing for COVID-19 (SARS-CoV-2) in ESKD https://ClinicalTrials.gov/show/NCT04378686
NCT04378595 Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin https://ClinicalTrials.gov/show/NCT04378595
NCT04377776 Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients https://ClinicalTrials.gov/show/NCT04377776
NCT04377724 Spread and Course of COVID-19 Infections https://ClinicalTrials.gov/show/NCT04377724
NCT04377685 Prediction of Clinical Course in COVID19 Patients https://ClinicalTrials.gov/show/NCT04377685
NCT04377490 Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy https://ClinicalTrials.gov/show/NCT04377490
NCT04378842 COVID-19 and ICU-acquired MDR Bacteria https://ClinicalTrials.gov/show/NCT04378842
NCT04378582 Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU https://ClinicalTrials.gov/show/NCT04378582
NCT04410718 Glycaemia and Cardiac Function in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04410718
NCT04393155 Longitudinal COVID-19 Cohort Study https://ClinicalTrials.gov/show/NCT04393155
NCT04386395 Immune Changes in Severe COVID-19 Pulmonary Infections https://ClinicalTrials.gov/show/NCT04386395
NCT04382781 Immunosupressive Treatment in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04382781
NCT04382508 Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults. https://ClinicalTrials.gov/show/NCT04382508
NCT04381273 Oral Health and Psychosocial Factors During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04381273
NCT04379297 COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE) https://ClinicalTrials.gov/show/NCT04379297
NCT04383678 Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04383678
NCT04383652 Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales https://ClinicalTrials.gov/show/NCT04383652
NCT04381351 Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction https://ClinicalTrials.gov/show/NCT04381351
NCT04380792 Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital https://ClinicalTrials.gov/show/NCT04380792
NCT04380779 Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses https://ClinicalTrials.gov/show/NCT04380779
NCT04380714 Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19 https://ClinicalTrials.gov/show/NCT04380714
NCT04384055 Predicting Outcomes for Covid-19 Using Sonography https://ClinicalTrials.gov/show/NCT04384055
NCT04383886 Evaluation of Emergency Department (ED) Staff Stress Level During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04383886
NCT04382794 Sitagliptin Treatment in Diabetic COVID-19 Positive Patients https://ClinicalTrials.gov/show/NCT04382794
NCT04382196 Impact of COVID-19 on Mental Health of Health Care Workers https://ClinicalTrials.gov/show/NCT04382196
NCT04385004 Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU https://ClinicalTrials.gov/show/NCT04385004
NCT04383444 Surveillance of Individuals Following SARS-CoV-2 Exposure https://ClinicalTrials.gov/show/NCT04383444
NCT04384250 Genetic Basis of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04384250
NCT04385238 Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04385238
NCT04383626 Fear Among Dentists During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04383626
NCT04389320 Antimalarial and Covid 19 in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT04389320
NCT04387786 Dornase Alfa Administered to Patients With COVID-19 (DACOVID) https://ClinicalTrials.gov/show/NCT04387786
NCT04386720 Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19. https://ClinicalTrials.gov/show/NCT04386720
NCT04386551 Detection of COVID-19 in Saliva Collection https://ClinicalTrials.gov/show/NCT04386551
NCT04385823 Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure https://ClinicalTrials.gov/show/NCT04385823
NCT04385147 Advanced Endoscopy During COVID-19 https://ClinicalTrials.gov/show/NCT04385147
NCT04384926 Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis https://ClinicalTrials.gov/show/NCT04384926
NCT04384887 “Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women” https://ClinicalTrials.gov/show/NCT04384887
NCT04409535 Effects of the COVID-19 Health Emergency on Biopsychosocial Health https://ClinicalTrials.gov/show/NCT04409535
NCT04388670 Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04388670
NCT04388579 Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19 https://ClinicalTrials.gov/show/NCT04388579
NCT04387279 The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT04387279
NCT04387214 COVID-19 Pandemic and Academic Performance of Veterinary Students https://ClinicalTrials.gov/show/NCT04387214
NCT04386460 Covid-19 and Prevention of Malnutrition After Confinement by Dentists https://ClinicalTrials.gov/show/NCT04386460
NCT04392401 COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study https://ClinicalTrials.gov/show/NCT04392401
NCT04389645 Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04389645
NCT04388657 COVID-19, bLOod Coagulation and Thrombosis https://ClinicalTrials.gov/show/NCT04388657
NCT04387799 Negative-PCR for Covid- 19 Pneumonia (NPC-19) https://ClinicalTrials.gov/show/NCT04387799
NCT04387643 Protecting Health Care Workers During the COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04387643
NCT04389567 Famotidine Outpatient COVID-19 Treatment Study https://ClinicalTrials.gov/show/NCT04389567
NCT04387656 NCI COVID-19 in Cancer Patients, NCCAPS Study https://ClinicalTrials.gov/show/NCT04387656
NCT04393428 Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04393428
NCT04392089 Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS https://ClinicalTrials.gov/show/NCT04392089
NCT04391738 Association Between BMI and COVID-19 https://ClinicalTrials.gov/show/NCT04391738
NCT04390126 COVID-19 Related Lockdown Effects On Chronic Diseases https://ClinicalTrials.gov/show/NCT04390126
NCT04389658 Contagiousness and Immunogenicity Status of COVID-19 in Asymptomatic Population (COVID-19 CONDITION) https://ClinicalTrials.gov/show/NCT04389658
NCT04389463 Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04389463
NCT04389489 Postpartum Sexual Function in Pregnant Women With COVID-19 https://ClinicalTrials.gov/show/NCT04389489
NCT04410835 Psychological Impact of the Corona Virus Pandemic in Individuals With Psychiatric Disorders https://ClinicalTrials.gov/show/NCT04410835
NCT04389515 Postoperative Recovery Index, Patient Expectations and Satisfaction With Prenatal Care Instrument in Pregnant Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04389515
NCT04395833 National Survey on the Lockdown of Children With Disabilities https://ClinicalTrials.gov/show/NCT04395833
NCT04394026 Imaging Feature of SARS-CoV2 Infection https://ClinicalTrials.gov/show/NCT04394026
NCT04393402 Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19) https://ClinicalTrials.gov/show/NCT04393402
NCT04392388 Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis https://ClinicalTrials.gov/show/NCT04392388
NCT04392245 Proctologic Practice and Covid-19 https://ClinicalTrials.gov/show/NCT04392245
NCT04391166 Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic https://ClinicalTrials.gov/show/NCT04391166
NCT04391816 COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study https://ClinicalTrials.gov/show/NCT04391816
NCT04394195 sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19? https://ClinicalTrials.gov/show/NCT04394195
NCT04393558 Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms https://ClinicalTrials.gov/show/NCT04393558
NCT04396197 Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care https://ClinicalTrials.gov/show/NCT04396197
NCT04401241 How Routine Biomarkers and Blood Leucocytes Count Can Assist Diagnosis of COVID-19 in Emergency Department https://ClinicalTrials.gov/show/NCT04401241
NCT04396210 Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04396210
NCT04395482 Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury https://ClinicalTrials.gov/show/NCT04395482
NCT04394429 Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04394429
NCT04393974 COVID-19 and Cancer Patients https://ClinicalTrials.gov/show/NCT04393974
NCT04410263 Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches https://ClinicalTrials.gov/show/NCT04410263
NCT04409197 Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network https://ClinicalTrials.gov/show/NCT04409197
NCT04394078 Impact of Covid-19 Pandemic on Depression and Quality of Life https://ClinicalTrials.gov/show/NCT04394078
NCT04414319 Severe Acute Respiratory Syndrome-Coronavirus-2 and Loss of Autonomy in the Elderly https://ClinicalTrials.gov/show/NCT04414319
NCT04397900 Blood Collection Study From COVID-19 Convalescents to Identify Immunogenic Viral Epitopes https://ClinicalTrials.gov/show/NCT04397900
NCT04397848 Mental Health Outcomes in Healthcare Workers During COVID-19 https://ClinicalTrials.gov/show/NCT04397848
NCT04397822 COVID-19: Study of INFLAmmasome and PLAtelets Functions https://ClinicalTrials.gov/show/NCT04397822
NCT04397588 Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19 https://ClinicalTrials.gov/show/NCT04397588
NCT04395300 Sleep Quality in Healthcare Personnel During COVID-19 https://ClinicalTrials.gov/show/NCT04395300
NCT04395755 Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed https://ClinicalTrials.gov/show/NCT04395755
NCT04395664 Arrhythmias in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04395664
NCT04405466 A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers https://ClinicalTrials.gov/show/NCT04405466
NCT04395391 Home Usability Study of the SARS-CoV-2 (COVID-19) Test https://ClinicalTrials.gov/show/NCT04395391
NCT04395924 Maternal-foetal Transmission of SARS-Cov-2 https://ClinicalTrials.gov/show/NCT04395924
NCT04394884 Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND) https://ClinicalTrials.gov/show/NCT04394884
NCT04400812 Attitude and Perception Towards COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04400812
NCT04400461 Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04400461
NCT04397172 Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19 https://ClinicalTrials.gov/show/NCT04397172
NCT04412460 Echocardiography in Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04412460
NCT04411511 COVID-19, Obesity and Lifestyle in Children https://ClinicalTrials.gov/show/NCT04411511
NCT04403607 Cardiac Imaging in SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04403607
NCT04403035 Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19 https://ClinicalTrials.gov/show/NCT04403035
NCT04402229 Psychological Impact of the Covid-19 Pandemic on Student Nurses https://ClinicalTrials.gov/show/NCT04402229
NCT04401371 Distance Learning for Dental Student During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04401371
NCT04401228 Predictive Models for Intensive Care Admission and Death of COVID-19 https://ClinicalTrials.gov/show/NCT04401228
NCT04400006 Ozone Therapy in the Prevention of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04400006
NCT04401085 COVID-19: Herd Immunity Study in the Czech Republic https://ClinicalTrials.gov/show/NCT04401085
NCT04404062 Validation of COVID-19 Tests https://ClinicalTrials.gov/show/NCT04404062
NCT04402853 SARS Cov-2 in Conjunctival Secretion https://ClinicalTrials.gov/show/NCT04402853
NCT04402814 IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With Nasopharyngeal PCR Testing. https://ClinicalTrials.gov/show/NCT04402814
NCT04401449 Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons https://ClinicalTrials.gov/show/NCT04401449
NCT04401098 Changing Of Egyptian Population Behaviour Towards COVID 19 Outbreak https://ClinicalTrials.gov/show/NCT04401098
NCT04401072 Attitude of Egyptian Population Toward COVID 19 in Ramadan https://ClinicalTrials.gov/show/NCT04401072
NCT04403880 Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19 https://ClinicalTrials.gov/show/NCT04403880
NCT04410939 COVID-19 PCR Test Results in Asymptomatic Pregnants https://ClinicalTrials.gov/show/NCT04410939
NCT04401436 COVID-19 Associated Lymphopenia Pathogenesis Study in Blood (CALYPSO) https://ClinicalTrials.gov/show/NCT04401436
NCT04403438 Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic https://ClinicalTrials.gov/show/NCT04403438
NCT04403061 Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome https://ClinicalTrials.gov/show/NCT04403061
NCT04406233 Muscle Mass and Strength as Predictors of Time to Discharge in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04406233
NCT04407299 COVID-19 Impact on Rheumatic Patients https://ClinicalTrials.gov/show/NCT04407299
NCT04402827 Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19. https://ClinicalTrials.gov/show/NCT04402827
NCT04406545 Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19. https://ClinicalTrials.gov/show/NCT04406545
NCT04413071 Cardiac COVID-19 Health Care Workers https://ClinicalTrials.gov/show/NCT04413071
NCT04403386 Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19 https://ClinicalTrials.gov/show/NCT04403386
NCT04403828 Impact of COVID-19 on Personal Protection Among Dentist in Egypt https://ClinicalTrials.gov/show/NCT04403828
NCT04406558 Psychological Impact of the Health Measures Generated by the COVID19 in Adolescents https://ClinicalTrials.gov/show/NCT04406558
NCT04404179 Setting up a COVID-19 Care Facility at a Prison in Pakistan https://ClinicalTrials.gov/show/NCT04404179
NCT04403932 Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency https://ClinicalTrials.gov/show/NCT04403932
NCT04404244 Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04404244
NCT04406844 An Observational Study to Identify the Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic and the Resulting Lockdown https://ClinicalTrials.gov/show/NCT04406844
NCT04408222 Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure https://ClinicalTrials.gov/show/NCT04408222
NCT04407143 Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection https://ClinicalTrials.gov/show/NCT04407143
NCT04405869 Thromboembolic Events in Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04405869
NCT04410107 Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19 https://ClinicalTrials.gov/show/NCT04410107
NCT04405973 Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO https://ClinicalTrials.gov/show/NCT04405973
NCT04405726 Clinical, Biological and Genetic Prognostic Factors for SARS-CoV-2 Infection in Patients Hospitalized in Strasbourg https://ClinicalTrials.gov/show/NCT04405726
NCT04413435 Clinical Characteristics of Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04413435
NCT04406090 Endovascular Thrombectomy in COVID-19 Infected Patients https://ClinicalTrials.gov/show/NCT04406090
NCT04406038 Study of the Spread of COVID-19 in Saint Petersburg, Russia https://ClinicalTrials.gov/show/NCT04406038
NCT04409899 The Utility of Enhanced Pre and Post-surgical Work-out to Prevent the Spread of COVID-19 in a Large Urology Department https://ClinicalTrials.gov/show/NCT04409899
NCT04405232 Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK https://ClinicalTrials.gov/show/NCT04405232
NCT04411576 Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare https://ClinicalTrials.gov/show/NCT04411576
NCT04416100 Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04416100
NCT04406571 Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer https://ClinicalTrials.gov/show/NCT04406571
NCT04408378 Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients https://ClinicalTrials.gov/show/NCT04408378
NCT04407663 Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually Near https://ClinicalTrials.gov/show/NCT04407663
NCT04407572 Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women https://ClinicalTrials.gov/show/NCT04407572
NCT04407533 Dietary Intake and Eating Habits During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04407533
NCT04407468 Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04407468
NCT04407429 Vienna Versus SARS-CoV-2 Virus Study https://ClinicalTrials.gov/show/NCT04407429
NCT04407273 STATIN THERAPY AND COVID-19 INFECTION https://ClinicalTrials.gov/show/NCT04407273
NCT04407117 Appendicitis During the National Lockdown During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04407117
NCT04407559 COVID-SErology in Rheumatoid Arthritis (COVID-19) https://ClinicalTrials.gov/show/NCT04407559
NCT04407494 Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19) https://ClinicalTrials.gov/show/NCT04407494
NCT04407260 The Use of Oxygen Hoods as Compared to Conventional High-flow Oxygen Delivery Systems, the Effects on Oxygenation, Intubation and Mortality Rates in Hypoxic Patients With COVID-19. https://ClinicalTrials.gov/show/NCT04407260
NCT04413058 Menstrual Cycle Characteristics of Healthcare Professionals https://ClinicalTrials.gov/show/NCT04413058
NCT04412473 COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject’s Habits https://ClinicalTrials.gov/show/NCT04412473
NCT04414410 Echocardiography in Critically-ill Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04414410
NCT04408326 Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04408326
NCT04407923 Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment https://ClinicalTrials.gov/show/NCT04407923
NCT04409275 LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION https://ClinicalTrials.gov/show/NCT04409275
NCT04409249 Prognosis in Pregnant With COVID-19 https://ClinicalTrials.gov/show/NCT04409249
NCT04418609 Neuro-COVID-19: Neurological Complications of COVID-19 https://ClinicalTrials.gov/show/NCT04418609
NCT04412031 Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient https://ClinicalTrials.gov/show/NCT04412031
NCT04411784 PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04411784
NCT04411459 Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04411459
NCT04416373 COVID-19 and Pregnancy Outcomes https://ClinicalTrials.gov/show/NCT04416373
NCT04416256 COVID-19 Pandemic and Worldwide Organ Procurement https://ClinicalTrials.gov/show/NCT04416256
NCT04410484 PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04410484
NCT04410432 Immune Response and Risk of Serious Infection to SARS-Cov2 https://ClinicalTrials.gov/show/NCT04410432
NCT04412265 Frailty in Elderly Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04412265
NCT04412304 Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04412304
NCT04411147 A Longitudinal Study of COVID-19 Sequelae and Immunity https://ClinicalTrials.gov/show/NCT04411147
NCT04413045 Novel COVID-19, A National Analysis https://ClinicalTrials.gov/show/NCT04413045
NCT04412746 Covid-19 and Diabetes in West of Algeria https://ClinicalTrials.gov/show/NCT04412746
NCT04412655 Primary Angioplasty for STEMI During COVID-19 Pandemic (ISACS-STEMI COVID-19) Registry https://ClinicalTrials.gov/show/NCT04412655
NCT04418544 Vocal Feature Analysis Algorithm https://ClinicalTrials.gov/show/NCT04418544
NCT04416061 The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04416061
NCT04418193 Patient Preference Trial for COVID-19 (PPT-COVID) https://ClinicalTrials.gov/show/NCT04418193
NCT04414657 USZ BioResource COVID https://ClinicalTrials.gov/show/NCT04414657
NCT04419571 Peri-Operative NLR in Emergency General Surgery During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04419571
NCT04419545 Covid Radiographic Images Data-set for A.I https://ClinicalTrials.gov/show/NCT04419545
NCT04418245 CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis https://ClinicalTrials.gov/show/NCT04418245

Registrires

nct_id brief_title link
NCT04314271 The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia https://ClinicalTrials.gov/show/NCT04314271
NCT04318314 COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04318314
NCT04315870 Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy. https://ClinicalTrials.gov/show/NCT04315870
NCT04323592 Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome https://ClinicalTrials.gov/show/NCT04323592
NCT04319016 Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy https://ClinicalTrials.gov/show/NCT04319016
NCT04320472 Acute Encephalopathy in Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04320472
NCT04321811 Behavior, Environment And Treatments for Covid-19 https://ClinicalTrials.gov/show/NCT04321811
NCT04323839 COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) https://ClinicalTrials.gov/show/NCT04323839
NCT04325412 Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY https://ClinicalTrials.gov/show/NCT04325412
NCT04327479 Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection https://ClinicalTrials.gov/show/NCT04327479
NCT04327570 In-depth Immunological Investigation of COVID-19. https://ClinicalTrials.gov/show/NCT04327570
NCT04327674 The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19 https://ClinicalTrials.gov/show/NCT04327674
NCT04329559 COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study https://ClinicalTrials.gov/show/NCT04329559
NCT04336956 Covid-19 Pediatric Observatory https://ClinicalTrials.gov/show/NCT04336956
NCT04331171 Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients’ Triage https://ClinicalTrials.gov/show/NCT04331171
NCT04331574 Renin-Angiotensin System Inhibitors and COVID-19 https://ClinicalTrials.gov/show/NCT04331574
NCT04333953 COVID-19 in Patients With HIV https://ClinicalTrials.gov/show/NCT04333953
NCT04341766 Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19 https://ClinicalTrials.gov/show/NCT04341766
NCT04334291 International COVID19 Clinical Evaluation Registry, https://ClinicalTrials.gov/show/NCT04334291
NCT04333875 Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis https://ClinicalTrials.gov/show/NCT04333875
NCT04336345 Outcomes of Patients With COVID-19 in the Intensive Care Unit https://ClinicalTrials.gov/show/NCT04336345
NCT04335773 COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology https://ClinicalTrials.gov/show/NCT04335773
NCT04347278 Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry https://ClinicalTrials.gov/show/NCT04347278
NCT04345536 Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital https://ClinicalTrials.gov/show/NCT04345536
NCT04337346 Evaluation of Covid 19 Anxiety in Endometriosis Patients https://ClinicalTrials.gov/show/NCT04337346
NCT04337320 Evaluation of Postnatal Outcomes of Covid 19 Positive Mothers Newborns https://ClinicalTrials.gov/show/NCT04337320
NCT04354519 The United Kingdom Multiple Sclerosis Register Covid-19 Substudy https://ClinicalTrials.gov/show/NCT04354519
NCT04353583 Renal Outcome in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04353583
NCT04340466 French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study https://ClinicalTrials.gov/show/NCT04340466
NCT04344249 Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04344249
NCT04344002 LunG canceR pAtients coVId19 Disease (GRAVID) https://ClinicalTrials.gov/show/NCT04344002
NCT04349982 ICU Trial in Critical Ill COVID‐19 Patients https://ClinicalTrials.gov/show/NCT04349982
NCT04348227 How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country’s ICU? https://ClinicalTrials.gov/show/NCT04348227
NCT04344912 Impact of COVID19 Outbreak in Cardiac Acute Care https://ClinicalTrials.gov/show/NCT04344912
NCT04347993 A Prospective “Universal” Observational Database for COVID-19 https://ClinicalTrials.gov/show/NCT04347993
NCT04347798 IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT https://ClinicalTrials.gov/show/NCT04347798
NCT04378452 Assessment of the Psycho-social Impact of COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04378452
NCT04357275 The RIsk Stratification in COVID-19 Patients in the ICU Registry https://ClinicalTrials.gov/show/NCT04357275
NCT04354701 COVID-19 and Cancer Consortium Registry https://ClinicalTrials.gov/show/NCT04354701
NCT04352764 ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings https://ClinicalTrials.gov/show/NCT04352764
NCT04351529 Austrian COVID-19 Registry https://ClinicalTrials.gov/show/NCT04351529
NCT04356586 Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms https://ClinicalTrials.gov/show/NCT04356586
NCT04366206 Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est https://ClinicalTrials.gov/show/NCT04366206
NCT04380766 Covid-19 Pandemic and Pancreatic Surgery in Italy https://ClinicalTrials.gov/show/NCT04380766
NCT04359927 Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry https://ClinicalTrials.gov/show/NCT04359927
NCT04359602 COVID-19 Recovered Volunteer Research Participant Pool Registry https://ClinicalTrials.gov/show/NCT04359602
NCT04374110 Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04374110
NCT04361591 COVID-19 in Liver Transplant Recipients https://ClinicalTrials.gov/show/NCT04361591
NCT04361500 Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter https://ClinicalTrials.gov/show/NCT04361500
NCT04364984 ARB, ACEi, DRi in COVID-19 https://ClinicalTrials.gov/show/NCT04364984
NCT04363632 Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04363632
NCT04365322 Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04365322
NCT04393142 Serologic Testing of Household Contacts of Confirmed Cases of COVID-19 https://ClinicalTrials.gov/show/NCT04393142
NCT04370821 COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers https://ClinicalTrials.gov/show/NCT04370821
NCT04368975 ARDS Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04368975
NCT04368234 Duke COVID-19 Shared Data and Specimen Repository https://ClinicalTrials.gov/show/NCT04368234
NCT04368143 COVID-19 Immune Repertoire Sequencing https://ClinicalTrials.gov/show/NCT04368143
NCT04367714 Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19 https://ClinicalTrials.gov/show/NCT04367714
NCT04380727 Almitrine and COVID-19 Related Hypoxemia https://ClinicalTrials.gov/show/NCT04380727
NCT04370067 Hungarian COVID-19 Epidemiological Research https://ClinicalTrials.gov/show/NCT04370067
NCT04368065 Registry to Study Factors That May Impact COVID-19 Occurrence and Severity https://ClinicalTrials.gov/show/NCT04368065
NCT04367857 ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04367857
NCT04367350 Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement https://ClinicalTrials.gov/show/NCT04367350
NCT04372199 SEVERITY SCORE FOR COVID-19 PNEUMONIA https://ClinicalTrials.gov/show/NCT04372199
NCT04371328 Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID Infection (Unit “COVID Possible”° https://ClinicalTrials.gov/show/NCT04371328
NCT04374045 Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study https://ClinicalTrials.gov/show/NCT04374045
NCT04373759 Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs https://ClinicalTrials.gov/show/NCT04373759
NCT04371744 QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19 https://ClinicalTrials.gov/show/NCT04371744
NCT04379440 Geriatric Population COVID-19 Observational Study (GEROCOVIDobs) https://ClinicalTrials.gov/show/NCT04379440
NCT04379544 Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19 https://ClinicalTrials.gov/show/NCT04379544
NCT04376398 Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals https://ClinicalTrials.gov/show/NCT04376398
NCT04390555 The Global PCHF-COVICAV Registry https://ClinicalTrials.gov/show/NCT04390555
NCT04388605 Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic https://ClinicalTrials.gov/show/NCT04388605
NCT04388436 Post Covid-19 Cardiopulmonary and Immunological Changes https://ClinicalTrials.gov/show/NCT04388436
NCT04386265 Compassionate Use of Hyperbaric Oxygen Therapy https://ClinicalTrials.gov/show/NCT04386265
NCT04389996 COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey https://ClinicalTrials.gov/show/NCT04389996
NCT04388631 Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health. https://ClinicalTrials.gov/show/NCT04388631
NCT04397575 The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients https://ClinicalTrials.gov/show/NCT04397575
NCT04387929 Detection of Anti-COVID-19 Antibody Levels in an Hospital Population https://ClinicalTrials.gov/show/NCT04387929
NCT04389554 D-dimer Levels in Pregnant With COVID-19 https://ClinicalTrials.gov/show/NCT04389554
NCT04394000 Impact of an Intensified Thromboprofylaxis Protocol in COVID-19 https://ClinicalTrials.gov/show/NCT04394000
NCT04393324 The Critical Care Response to the COVID-19 Pandemic in Madrid https://ClinicalTrials.gov/show/NCT04393324
NCT04394390 Do Vitamin D Levels Really Correlated With Disease Severity in COVID-19 Patients? https://ClinicalTrials.gov/show/NCT04394390
NCT04395794 SARS-CoV-2 Disguise Study https://ClinicalTrials.gov/show/NCT04395794
NCT04408339 COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking https://ClinicalTrials.gov/show/NCT04408339
NCT04401033 Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study) https://ClinicalTrials.gov/show/NCT04401033
NCT04401540 Characteristics of Neonatal Covid-19 in Turkey https://ClinicalTrials.gov/show/NCT04401540
NCT04403672 Performance Evaluation of RealDetectâ„¢ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus https://ClinicalTrials.gov/show/NCT04403672
NCT04411563 Epigenetic Tools as Prognostic Predictors in Covid19 https://ClinicalTrials.gov/show/NCT04411563
NCT04410471 Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients https://ClinicalTrials.gov/show/NCT04410471
NCT04412551 Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19 https://ClinicalTrials.gov/show/NCT04412551
NCT04416009 Extracellular Water in Covid 19 Pneumonia https://ClinicalTrials.gov/show/NCT04416009
NCT04418557 COVID-19 and Obstetric Transmission https://ClinicalTrials.gov/show/NCT04418557